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SUMMARY
The sub-types of alpha-adrenoceptors which mediate 
pressor responses to sympathomimetic agonists or to 
nerve stimulation in pithed rabbits have been classified 
according to the effects of "selective" antagonists and 
a comparison has been made, for the alpha 2 subtype, with 
corresponding responses in the rat.
In the rabbit the d o s e - r e s p o n s e  curve for 
phenylephrine was shifted to the right in parallel by 
prazosin (1 mg/kg) and was unaffected by rauwolscine 
(lmg/kg). The dose-response curve for noradrenaline 
was shifted to the right by prazosin (1 mg/kg) and was 
shifted to a smaller extent by rauwolscine (lmg/kg) or 
imiloxan (10 mg/kg). After rauwolscine, prazosin 
produced a rightward shift larger than when given alone. 
After prazosin, rauwolscine produced a rightward shift 
larger than when given alone.
The responses to pressor nerve stimulation at low 
f r e q u e n c i e s  (<lHz) could be reduced by prazosin, 
rauwolscine or imiloxan but those at higher frequency 
could be reduced only by prazosin.
These results indi c a t e  that the responses to 
noradrenaline or to nerve stimulation are mediated by 
both alpha^- and alpha 2 ~adrenoceptors. Low doses or
(xvm )
frequencies have a proportionately greater component 
which is alpha2.
R e s p o n s e s  to n o r a d r e n a l i n e  after p r a z o s i n  
(1 mg/kg), were sufficiently sensitive to rauwolscine to 
be considered as predominantly alpha2 . A comparison 
w a s  t h e r e f o r e  mad e  of p r a z o s i n - r e s i s t a n t  p r e s s o r  
responses to noradrenaline in the rat and rabbit. 
Pressor responses to noradrenaline were produced by a 
lower dose per unit body weight in the rat whereas this 
was less marked for the alpha2”"a(3renoceptor agonist 
guanabenz. In the rabbit p r e ssor r e s p onses to
noradrenaline were more susceptible to blockade by 
rauwolscine but were less sensitive to Wy 26703 than in 
the rat. This d e m o n s t r a t e s  that the a l p h a 2 -
adrenoceptors mediating pressor responses ±n vivo* like 
those in other tissues in v i tro, are different in rat 
and rabbit, with regard to sensitivity to antagonists.
The fractions of alpha versus non-alpha components 
of vasopressor responses were assessed in the pithed rat 
preparation.
Sympathetic pressor nerves exit from the spinal 
cord over most of the thoraco-lumbar outflows, the 
o p t i m u m  region for e v o k i n g  i n c r e a s e s  in s y s t e m i c  
arterial blood pressure being Tg - Tg. This region was 
therefore chosen for the study of the involvement of 
p u r i n e r g i c  c o - t r a n s m i s s i o n  in s y m p a t h e t i c  nerve
(X\X)
transmission. In the case of the vas deferens, maximal 
responses were obtained by stimulation at regions T ^ 3  ~ 
1*1 (McGrath, 1973).
The involvement of purines in the pressor responses 
to stimulation of the spinal sympathetic outflow was 
investigated by the following methods.
Firstly the position was found in the spinal column 
where the pithing rod electrode should be placed to give 
large responses suitable for investigating the relative 
involvement of the components within the response. This 
allowed d e t e r m i n a t i o n  of the o p t i m u m  s t i m u l a t o r y  
parameters for the alpha-blocker - resistant component 
of the sympathetic pressor response which could be 
u n m a s k e d  by g i v i n g  c o m b i n e d  a l pha^- and a l p h a 2 ~ 
adrenoceptor blockade.
Secondly a suitable protocol was developed for the 
use of the best P 2 '"PU rinoceptor desensitising agent 
a v a i l a b l e  ,^,j^-mATP. After d e s e n s i t i s a t i o n ,  its 
influence on nerve mediated responses was assessed.
Finally responses to ATP and mATP were studied and 
compared with the responses obtained by sympathetic 
stimulation.
These first two approaches have been used in the 
past but to limited success (Flavahan et al,1985),
(xx)
mainly due to the ineffective dosage of mATP employed.
The P 2 - purinoceptor desensitising agent mATP was 
believed to be a very stable analogue of ATP (Delbro et 
alf1985). It was on this assumption that investigations 
were carried out on responses obtained to sympathetic 
nerve stimulation after 'desensitisation' with a single 
dose of mATP. However the stability and effectiveness of 
mATP in vivo could be much less that reports from in 
vitro studies suggest (Milner-White & Rycroft, 1983) 
since they take into account only one of the enzyme 
reactions which degrade ATP and none of the uptake or 
dissipating mechanisms which occur in vivo. Therefore it 
seemed possible that the limited success of other 
workers was due to the ineffectiveness of mATP rather 
than b e c a u s e  there w a s  l i t t l e  or no p u r i n e r g i c  
involvement.
Based on this experience with vasopressor responses 
an examination was made of other systems, in which NANC 
components had been reported, in an attempt to identify 
any NA N C  c o m p o n e n t s  in nerve m e d i a t e d  d e p r e s s o r  
responses, vas deferens motor responses and in nerve 
mediated bronchodilator responses in the lung.
Stimulation of the spinal outflow between regions 
L5 and S2  produced depressor responses. These responses 
were unaffected by adrenergic, cholinergic or purinergic 
antagonists.
(xxi)
Several responses to nerve stimulation in the 
pelvic viscera show the pharmacological profile of NANC 
transmission. One such response is that to stimulation 
of motor responses from the rat vas deferens (Ambache & 
Zar, 1971; McGrath, 1978). By re-examining this in situ 
in the pithed rat it was possible to investigate the 
p u r i n e r g i c  i n v o l v e m e n t  in these m o t o r  responses. 
Blockade of the P2 _purinoceptors by mATP attenuated the 
m o t o r  r esponse to the vas d e f e r e n s  by about 80%, 
therefore indicating a very large purinergic component 
at the stimulatory parameters used. Measured at the same 
time as the pressor responses to sympathetic nerve 
stimulation, the contraction of the vas deferens in situ 
p r o v i d e d  an a s s a y  for the t i m e  c o u r s e  of the 
effectiveness of mATP in vivo.
In conditions of high resting airway smooth muscle 
tone, stimulation of the sectioned left vagal nerve 
bundle produced bronchodilations which were neither 
a d r e n e r g i c  nor cholinergic. Studies on the NA N C  
inhibitory system in the cat lung have been both scarce 
and unproductive. Previous experimenters used non­
specific drugs like quinidine for characterising and 
investigating any purinergic element in the response.
In an attempt to characterise the neurotransmitter 
associated with the respiratory NANC inhibitory system 
in the cat, the effects of two purinoceptor blockers,
(xxu)
mATP for P2 ~purinoceptors, and 8-phenyltheophylline (8- 
PT) for P^-purinoceptors were studied. This showed that 
w h i l e  m A T P  h a d  no e f f e c t  on n e r v e  m e d i a t e d  
b r o n c h o d i l a t i o n s ,  8 PT a t t e n u a t e d  these responses, 
therefore indicating P^ rather than P 2 ” Purinoceptor 
involvement in the responses.
(xxw^
INTROPU.CTION; PARE In 
SYMPATHETIC NEPRQ.QBEMXCAL .TRANSMISSION
1
Sympathetic Nenrochemical Transmission
The concept that nervous impulses are transmitted 
across synapses and neuroeffector junctions by chemical 
mediators has been proposed since the turn of the 
twentieth century and superceded the previous theory of 
electrical transmission.
In 1901 Langley showed that the pressor response 
obtained on stimulation of sympathetic nerves was 
similar to the increase in blood pressure noted when 
adrenal extract was injected in vivo (Oliver & Schafer, 
1894) and that this effect remained after denervation 
indicating a site of action on the effector system and 
not via the nerves.
The identity of the chemical responsible for the 
p r e s s o r  a c t i o n  of the ad r e n a l  e x t r a c t  w a s  t e r m e d  
adrenaline because of its close association with the 
adrenal medulla. It was not long after Oliver and 
Schafer's o b s e r v a t i o n  that this acti v e  sub s t a n c e  
a d r e n a l i n e  w a s  i s o l a t e d  (Abel & Crawford, 1897? 
Takamine, 1901; Aldrich, 1901) and later synthesised 
(Stolz, 1904; Dakin, 1905; Abel & Taveau, 1905). However 
it was not until Elliot (1905) suggested that this 
active substance from the adrenal extract may also be 
liberated from sympathetic nerve endings that the 
possibility of chemical transmission took a step closer 
to reality.
2
The first c o n c l u s i v e  e v i d e n c e  that c h e m i c a l  
transmission occurs came from Loewi (1921). When two 
frog hear t s  w e r e  set up and p e r f u s e d  so that the 
perfusate flowed from the first to the second heart and 
the sympathetic nerve innervating the first heart was 
stimulated, it not only caused that heart to beat faster 
and stronger but this effect was also soon observed in 
the second heart, w i t h o u t  the second heart b e ing 
directly stimulated via its sympathetic nerves. Loewi 
c o n c l u d e d  t h a t  a s u b s t a n c e  ( w h i c h  he t e r m e d  
1acceleranstoff') was released from the sympatheic 
nerves, and that this substance was transported via the 
perfusate to cause the observed effects on the second 
heart. The striking similarity between the action of 
Loewi's 'acceleranstoff' and that of adrenaline on frog 
tissue led to investigations which eventually proved 
adrenaline to be the sympathetic transmitter in the 
frog.
However in mammals the sympathetic transmitter was 
shown to be noradrenaline rather than adrenaline. The 
evidence for this came as a result of a number of 
investigations.
The first evidence showing that noradrenaline 
mimicked responses to sympathetic nerve stimulation more 
closely than did adrenaline, appeared as early as 1910 
(Barger & Dale, 1910) but was overlooked until 1921 when
3
C a n n o n  & Uridil n oted that the a c t i o n s  of an 
adrenaline-like substance, which was liberated on 
stimulation of sympathetic nerves, did not closely match 
those of adrenaline. He concluded that it was this 
adrenaline-like substance and not adrenaline that was 
released during sympathetic nerve transmission and named 
this substance 'sympathin' to indicate its association 
with sympathetic nerves and to distinguish it from 
adrenaline.
In a Loewi-type experiment, Finkleman in 1930 
suspended one segment of rabbit intestine above another 
and allowed Locke's solution to flow from the first onto 
the second segment. Stimulation of sympathetic nerves to 
the upper tissue caused inhibition of its spontaneous 
movements and tissue relaxation, followed by a similar 
response in the second, lower preparation after a short 
delay. He showed that these effects were similar to 
those obtained by additions of adrenaline.
Clearly therefore the role of noradrenaline as the 
s y m p a t h e t i c  n e u r o t r a n s m i t t e r  had still not been 
universally recognised. It was Von Euler in 1946 who 
showed that the main sympathetic transmitter was 
noradrenaline since very little adrenaline was present 
in s y m p a t h e t i c a l l y  i n n e r v a t e d  tissue w h e r e a s  the 
c o n c e n t r a t i o n  of n o r a d r e n a l i n e  w a s  ver y  high by 
comparison. Furthermore, after sympathectomy of the 
tissues being studied, Von Euler showed a decrease in
4
n o r a d r e n a l i n e  l e v e l s  i n d i c a t i n g  n o r a d r e n a l i n e  
association with nerve rather than muscle and that the 
’s y m p a t h i n 1 of Cannon's e x p e r i m e n t s  b e h a v e d  like 
noradrenaline.
Adrenoceptors
Early in the history of the study of noradrenaline, 
it was appreciated that there were two main types of 
action (contraction or relaxation) which could be 
produced by noradrenaline or adrenaline.
Dale in 1906 s h o w e d  that the pr e s s o r  effect 
obtained by the addition of adrenaline in the cat in 
vivo, could be changed into a depressor response by 
p r e t r e a t i n g  w i t h  ergot. Hence it w a s  s h o w n  that 
adrenaline has two effects, vasoconstriction (the 
dominant effect) and vasodilation (which can be unmasked 
on addition of ergot which blocks the vasoconstrictor 
effect).
Can n o n  & R o s e n b l e u t h  (1933) p o s t u l a t e d  that 
'sympathin' (noradrenaline) or adrenaline had dual 
effects because 'sympathin 'and adrenaline could combine 
w i t h  either of two s u b s t a n c e s  to p r o d u c e  either 
'sympathin E' (resulting in excitation) or 'sympathin I' 
(resulting in inhibition).
5
This view was different to Langley's (1905) in that 
he envisaged two 'receptive substances' were fixed 
components of the effector cells and that a response 
(which depended on which one of the receptive substances 
was involved) occured on combination of transmitter with 
either of the receptive substance types. Hence the 
differences in responses were due to differences in the 
receptor sites on the effector cells and on the chain of 
events that occur after interaction of transmitter with 
these sites. Langley's view is essentially the current 
view since there is no evidence that noradrenaline (the 
sympathetic neurotransmitter) is modified in any way 
before initiating a response at the effector cells.
By c o m p a r i n g  r e l a t i v e  p o t e n c i e s  of six 
sympathomimetics on a variety of tissues, Ahlquist 
(1948) noted that the order of potency differed between 
the smooth muscle types. For example, the order of 
potency for smooth muscle producing contraction was 
different to that producing relaxation, whilst the order 
of potency for stimulation of the heart was similar to 
that in smooth muscle that produced relaxation. This led 
to the postulation that two types of receptor ('alpha' 
and 'beta' ) existed. For muscle with 'alpha' receptor 
d o m i n a n c e  a d r e n a l i n e  and n o r a d r e n a l i n e  w e r e  m o s t  
s e n s i t i v e  w h i l s t  i s o p r e n a l i n e  w a s  p r a c t i c a l l y  
insensitive. Those tissues with 'beta' receptors, were 
s e n s i t i v e  to i s o p r e n a l i n e  but less s e n s i t i v e  to 
adrenaline and noradrenaline. This concept of alpha and
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beta-adrenoceptors is now universally accepted and 
supported with the discovery of selective receptor 
antagonists.
So far the discussion has centered on receptors 
being located on the effector muscle. However the 
discovery of presynaptic alpha-adrenoceptors led to the 
pharmacological subdivision of alpha-adrenoceptors. This 
subdivision was stimulated by the multiple actions of 
the alpha-adrenoceptor blocking drug phenoxybenzamine 
(Brown & Gillespie, 1956). These receptors differed not 
only in l o c a t i o n  but also in effect, since these 
receptors did not produce contraction or relaxation like 
their p o s t - j u n c t i o n a l  c o u n t e r p a r t s ,  but m e d i a t e d  
inhibition of transmitter release from sympathetic nerve 
terminals in a negative feedback mechanism (mechanisms 
of w h i c h  are d e t a i l e d  in r e v i e w s  by Langer,1974; 
Starke,1977; Westfall, 1977; Vizi,1979).
The suggestion that pre and postsynaptic alpha- 
adrenoceptors differed came from observations made in 
the rabbit heart and cat spleen. At the presynaptic 
release-inhibiting receptors in the rabbit heart the 
relative potencies of phenylephrine, oxymetazoline and 
naphazoline differed with their relative potencies 
postsynaptically (Starke 1972), and in the cat spleen 
phenoxybenzamine was more potent postsynaptically than 
presynaptically (Langer,l973). As a result of these 
studies Langer s u g g e s t e d  (1974) that p o s t s y n a p t i c
7
r e c e p t o r s  should be r e f e r r e d  to as alpha^ and 
presynaptic receptors alpha2 «
However, there is now evidence for the occurence of 
both alphaj and alpha2  postjunctional adrenoceptors and 
t h e r e f o r e  s u b d i v i s i o n  on the basis of a n a t o m i c a l  
location is no longer a useful method of classification.
The well defined antagonism of prazosin on the 
contractile effect of noradrenaline in human visceral 
arteries was not observed in human digital arteries, 
which had a large prazosin resistant component (Moulds & 
Jauernig, 1977; Jauernig et al, 1978). Drew and Whiting 
(1979) extended this study by showing that prazosin 
strongly antagonised the pressor effect of phenylephrine 
in cats and rats but was not as effective against the 
pressor response to noradrenaline , whilst yohimbine was 
more potent against noradrenaline pressor responses than 
against p h e n ylephrine. As o b s e r v e d  by M o u l d s  and 
Jauernig (1977), Drew and Whiting also showed that this 
b l o c k i n g  eff e c t  of p r a z o s i n  against noradrenaline 
pressor responses was not consistent when comparing 
different vascular beds. The pressor responses to 
noradrenaline were relatively resistant to prazosin in 
the cat hindlimb and mesenteric vascular beds but not in 
the renal vasculature. The conclusion of this study 
explained that phenylephrine constricts blood vessels 
via the prazosin sensitive alpha^ receptors whereas 
noradrenaline acts through both the alpha^-adrenoceptor
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and an adrenoceptor which is insensitive to prazosin.
This prazosin resistant site of action has now been 
classified as alpha 2 « The pressor effects of selective 
alpha 2 ~adrenoceptor agonists in the pithed rat were 
unaffected by prazosin but were antagonised by the 
alpha 2 ~adrenoceptor antagonist yohimbine whilst the 
p r e s s o r  respo n s e  to p h e n y l e p h r i n e  w a s  m a r k e d l y  
attenuated by prazosin and only slightly affected by 
yohimbine (Docherty et al f197 9? Docherty and McGrath, 
1980a). This observation has been repeated with a 
variety of alpha-adrenoceptor agonists all showing that 
the vasoconstriction they produce is at least partly 
resistant to alpha^ blockade and that the resistant 
c o m p o n e n t  can be b l o c k e d  by a l p h a 2 - a d r e n o c e p t o r  
antagonists, indicating a role for alpha2 ~a<3 renoceptors 
post-junctionally (Timmermans et al, 197 9? Drew, 1980; 
Plavahan & McGrath, 1980; Kobinger & Pichler, 1980? 
T i m m e r m a n  and van Zwieten, 1980? Madjar et al, 1980). 
The post-junctional alpha2 “adrenoceptor population may 
not be homogeneous and could vary in location (synaptic 
and extra-synaptic) (McGrath, 1982a) as well as between 
species (Alabaster et al, 1986).
■Sympathetic Neurovascular Transmission
It has now also been p r o p o s e d  that in blood 
vessels, alpha-adrenoceptors- the proposed site of
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action of the sympathetic neurotransmitter- are unlikely 
to be the only site of sympathetic mediation since many 
examples have been found where vascular responses to 
nerve stimulation remain partly resistant to alpha 
blockers. Recently two alternative proposals of alpha- 
mediated sympathetic transmission have been postulated 
inorder to explain experimental observations in isolated 
tissues.
Firstly the 'gamma-adrenoceptor' hypothesis (Hirst 
& Neild, 1980) suggests that noradrenaline is the 
transmitter but the junctional receptors are not alpha- 
adrenoceptors.
S e c o n d l y  the ' c o - t r a n s m i t t e r 1 hypothesis puts 
forward the idea that another transmitter is released 
along with noradrenaline. Several candidates have been 
proposed as the neurotransmitter involved in the co­
t r a n s m i s s i o n  i n c l u d i n g  a d e n o s i n e  and the adenine  
nucleotides (Burnstock & Sneddon, 1985).
P r e l i m i n a r y  i n v e s t i g a t i o n s  of the r e l a t i v e  
contributions to vascular neurotransmission from sub- 
types of alpha-adrenoceptor, unmasked an alpha-blocker- 
resistant component (Flavahan et al, 1985) in the 
vascular sympathetic response of the pithed rat. This 
non-alpha component of the pressor response could be 
slightly attenuated by the purinergic desensitising 
agent mATP, but only after a l p h a - a d r e n o c e p t o r
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antagonists had been added to block the alpha component 
of the response (Flavahan et al, 1985? Grant et al, 
1985). This indicated a role, however minor, for purines 
in vascular sympathetic co-transmission.
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INTRODUCTION; PART 1 
PURINES
12
The Pharmacological m M  Physiological roles Purines.
Drury & Szent-Gyorgi (1929) first investigated the 
actions of purines on the heart and cardiovascular 
system by showing that crude heart, brain, kidney and 
spleen extracts caused negative chronotropic effects on 
the heart and identified the active constituent as AMP. 
They further showed that adenosine prepared from yeast 
affected the heart in a similar way, as well as dilating 
arterial and coronary blood vessels, and inhibiting 
spontaneously active intestinal smooth muscle. The 
depressor effects of purines were also noted by Green & 
Stoner (1950).
Recent studies of cardiac hypoxia and hyperaemia 
have r e v e a l e d  a p o s s i b l e  p h y s i o l o g i c a l  role for 
adenosine (formed from the intracellular degradation of 
ATP) by indicating a link between myocardial adenosine 
levels and coronary blood flow (Berne, 1963; Berne, 
1980; Mustafa,1980). The coronary vasodilatory effects 
of adenosine are blocked by the methylxanthines (Bunger 
et al, 197 5). ATP has now been shown to be more potent 
than adenosine in inducing coronary vasodilation (Wolf & 
Berne, 1956; Moir & Downs, 1973) and is shown to be 
present in perfusates from hypoxic hearts (Paddle & 
Burnstock, 1974). These effects are distinct from the 
adenosine effects since they cannot be blocked by the
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methylxanthines (Giles & Wilken, 1977).
This blood flow regulating role of adenosine and 
ATP has been extended from the coronary circulation and 
has now been proposed to play a role in other vascular 
beds including the skeletal muscle (Boyd & Forrester, 
1968; Berne et al, 1975), renal (Haddy & Scott, 1968), 
adipose tissue (Sollevi & Fredholm, 1981) and cerebral 
(Rubio et al, 1975). The source of these purines, 
neuronal or non-neuronal, has yet to be determined 
(Burnstock, 1982).
The vascular effects of ATP were first linked to 
nerves when Holton and Holton (1954) proposed that ATP 
released from sensory nerves during antidromic nerve 
stimulation caused the observed vasodilation in the 
rabbit ear artery, and later showed that rabbit ear 
vessel dilation was accompanied by ATP release (Holton, 
1959) .
Enrinergic receptors and their su.b.Qlassification.
In 1978, Burnstock distinguished two types of 
peripheral purine receptors; P^-purinoceptor and P 2 ” 
purinoceptor (Table 1). Adenosine and AMP were more 
potent than ATP at P^-purinoceptors and were antagonised 
by methylxanthines like theophylline. P^-purinoceptor 
activation leads to changes in cAMP via a modulation of 
adenylate cyclase activity.
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Table 1
Two types of peripheral purinoceptor have been 
identified in various tissues: the P-^ - and the P2“ 
purinoceptor. Both of these receptor types have now 
been further subdivided according to function, 
agonist potency, and p r e f e r e n t i a l  antagonist.  
Details of these subdivisions are given in the 
text.
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However at P2 -purinoceptors, ATP and ADP were more 
potent than adenosine, and they were not antagonised by 
methylxanthines. It was later shown that responses 
mediated via these receptors could be specifically 
antagonised by arylazido amino propionyl ATP (ANAPP3) 
(Hogaboom et al, 1980) or desensitised by methylene
A T P  ( K a s a k o v  & B u r n s t o c k ,  1983) t h u s  f u r t h e r  
substantiating the P1 /P 2  hypothesis.
£ 1  receptors
A d e n o s i n e  r eceptor s u b t y p e s  w e r e  o r i g i n a l l y  
classified by a biochemical approach. This led to some 
confusion in the nomenclature as the various groups of 
workers adopted different nomenclature according to the 
system studied, when comparing and contrasting the 
receptor subtypes.
Using the criterion of receptor location, the 
adenosine receptors were first subdivided into ,R I and 
'P' sites (Londos & Wolff, 1977), where 'R' designated 
requirement for an intact ribose ring for receptor 
interaction to mediate changes in adenylate cyclase 
a c t i v i t y .  T h e s e  'R' s i t e s  a r e  l o c a t e d  
extracellularly.'P' sites require intact purine ring; 
these sites are thought to have intracellular location 
and are not thought to contribute to the actions of 
exogenously administered adenosine in vivo (Braun &
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Levitski, 1979).
The extracellular receptors are further subdivided 
into two classes of cell membrane adenosine receptors. 
This s u b d i v i s i o n  has bee n  b ased on t w o  types of 
observation.
Firstly, adenosine receptor activation can have 
either stimulatory or inhibitory effects on adenylate 
cyclase activity in isolated cells. The corresponding 
receptor subtypes are designated Ra and Ri respectively 
(Londos et al, 1980). Similarly, Van Calkner and co­
workers (1979) made a subdivision of the adenosine 
receptor but this time on the basis of how receptor 
activation affected cAMP accumulation: A 2  receptors
increasing cAMP accumulation; A^ recptors inhibiting 
cAMP accumulation.
Secondly, a series of adenosine analogues exhibit 
two different and distinct orders of potency on a range 
of both biochemical and pharmacological preparations. 
The Ra/A 2  receptor is more susceptible to 5* - N- 
ethylcarboxamide adenosine (NECA) and less responsive to 
L-N^-phenyl isopropyladenosine (L-PIA) whereas the 
reverse is true for the Ri/A 2  receptor (Bruns et al,
1980).
S i m p l i f y i n g  these above c l a s s i f i c a t i o n s  of 
extracellular adenosine receptors, it is possible to
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combine them such that P^a receptors are equivalent to 
Ra & A 2  whereas P]^ receptors are equivalent to Ri & 
(Brown & Burnstock, 1981).
The P2  receptors
From potency studies of the structural analogues of 
ATP, the P2 ~purinoceptor was further divided into P2 X & 
P2 y subclasses. At the P2 y-purinoceptor, 2-methylthio- 
ATP was more potent than ATP, and ^,(&m ATP was less 
potent than ATP in producing a response, whereas at the 
P 2 x- p ur inoceptor, phosphate modified analogues of ATP 
(like ATP) were more potent than ATP in producing a
response (Burnstock & Kennedy, 1985).
The P 2 X-purinoceptors, whose activation causes 
contraction of vascular smooth muscle (Burnstock & 
Warland, 1987a) may be antagonised by ANAPP3 (Hogaboom 
et al, 1980) or desensitised by &,jlm ATP (Kasakov & 
B u r n s t o c k ,  1983; D e l b r o  et al, 1985). The p2 y ” 
purinoceptor, whose activation causes relaxation of 
vascular smooth muscle (Burnstock & Warland, 1987b) may 
be antagonised by Reactive Blue 2 (Kerr & Krantis, 1979; 
Burnstock & Warland, 1987b).
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ATP; Principle neurotransmitterr co-transmitter nz
neuromodulator?
ATP; A  Principle Neurotransmitter.
Despite earlier reports of 'atropine-resistant' 
parasympathetic nerve mediated responses occuring in the 
gastrointestinal tract and bladder (Langley & Anderson, 
1895a? Langley, 1898; Ambache, 1951) it was not until 
the 1960's that autonomic nerves other than adrenergic 
and cholinergic were suggested (Paton & Vane, 1963; 
Burnstock et al, 1963? 1964? 1966). These are the non- 
adrenergic non-cholinergic (or NANC) nerves.
Som e  of the s u b s t a n c e s  a s s o c i a t e d  w i t h  NA N C  
transmission have now been identified and established as 
neurotransmitters. Evidence suggests that ATP, which 
fits all the necessary criteria to be identified as a 
neurotransmitter, could be the transmitter associated 
with some of the NANC responses (Burnstock et al, 1970? 
1972) .
Firstly, systems for the synthesis and storage of 
ATP were shown to be present in nerve terminals. One 
problem in suggesting ATP as a neurotransmitter was not 
in its rarity but rather in its abundance, since it is 
present in cells as a high energy metabolite in both 
neural and non-neural tissue. It was not until specific
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storage compartments for ATP were suggested (Su et 
al,1971) and finally observed as 'large opaque vesicles' 
(Robinson et al, 1971; Burnstock & Iwayama, 1971) that 
ATP became a serious contender.
Secondly, ATP w a s  s h o w n  to be r e l e a s e d  on 
stimulation of nerves from the taeni coli and the 
bladder, by using the sensitive ATP-specific firefly 
luciferin-luciferinase assay (Burnstock et al, 1978). 
However most excitable tissues can release ATP including 
muscle cells thus making interpretation of results more 
complex as well as providing a major stumbling block to 
the purinergic hypothesis.
Thirdly, exogenous administration of ATP mimicked 
the response to nerve stimulation by acting on post­
s y n a p t i c  r e c e p t o r s  for ATP. For e x a m p l e  in the 
intestine, ATP causes a relaxation of a type which 
exactly mimics the NANC responses (Ambache & Zar, 1970; 
Dean & Downie, 197 8 ) and in the bladder ATP produces a 
contractile response which wanes rapidly in a way which 
mimics that to NANC nerve stimulation (Burnstock et al,
1972) .
Fourthly, mechanisms for terminating the action of 
released ATP exist, either by enzymic degradation or by 
uptake mechanisms. These mechanisms not only exist, but 
are very e f f i c i e n t  as o b s e r v e d  by the very short 
duration of action of both exogenously applied ATP and
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of NANC nerve stimulation. Until recently it was 
thought that only adenosine underwent re-uptake but in 
1970 Chaudry & Gould showed the existence of an uptake 
mechanism for ATP as well. The action of dipyridamole is 
to block the uptake of adenosine. This is shown by a 
decreased uptake of ^H-adenosine (Satchell et alf 1973; 
Satchell & Burnstock, 1975; Macguire & Satchell, 1979). 
The enzymes responsible for the degradation of ATP are 
the ATPases which are located on cell plasma membranes 
(Manery & Dryden, 1979) and can almost completely 
degrade ATP to AMP on a single passage through the rat 
heart and lung (Baer & Drummond, 1968). 5'-adenylate 
kinase, nucleoside diphosphatase and 5'- nucleotidases 
all play a part in the degradation of ADP and AMP to 
adenosine (Macguire & Satchell, 1981). Adenosine itself 
can undergo deamination by adenosine deaminase (which 
can be inhibited by erthro-9-2-hydroxy-3-nonyl adenine 
(EHNA) (Macguire & Satchell, 197 9)) to inosine or can be 
taken up into the nerves or smooth muscle.
Finally, drugs which modify the response to nerve 
stimulation have a similar effect on the response to 
e x o g e n o u s l y  a p p l i e d  ATP. The lack of s p e c i f i c  
a n t a g o n i s t s  of ATP d e l a y e d  the a c c e p t a n c e  of the 
'purinergic nerve 1 hypothesis for some time. Initial 
examinations using high concentrations of non-specific 
blockers of the ATP response like quinidine (Burnstock 
et al, 1970) phentolamine and similar imidazolines 
(Satchell et al, 1973; Tomita & Watanabe, 1973)and 2,2'-
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pyridylisatogen (Hooper et al, 1974) yielded some 
promising results but no conclusive evidence.
Apamin, a bee neurotoxin, inhibits the relaxant 
effects and inhibitory junction potentials (i.j.p.s) to 
both nerve stimulation and ATP in the guinea-pig taenia 
coli (Vladmirova & Shuba, 1978) but this compound once 
again is non-specific and acts by blocking K+ channels 
rather than as a s p e c i f i c  c o m p e t i t i v e  blocker of 
p u r i n e r g i c  r e c e p t o r s  ( Ba n k s  et al, 1979). The 
development of ANAPP 3 (Hogaboom et al, 1981), an ATP 
analogue and specific ATP receptor antagonist brought 
about more conclusive evidence. ANAPP 3 specifically 
blocks responses to nerve stimulation and to ATP in the 
guinea-pig bladder (Westfall et al, 1980) cat bladder 
(Theobald, 1983) and in the guinea-pig vas deferens 
(Fedan et al, 1981). However in some preparations, like 
the guinea-pig stomach fundus (Frew & Lundi, 1982) and 
rabbit anococcygeus (Sneddon et al, 1982), responses to 
both ATP and nerve stimulation remain unaffected by 
ANAPP 3 . Discrepancies also exist in the guinea-pig 
taenia coli where ATP relaxations but not NANC nerve 
mediated relaxations are blocked by ANAPP 3 (Westfall et 
al, 1981; 1982). The slowly degradable analogue of ATP 
(oC,^ 3m ATP) (Milner-White & Rycroft, 1983) is identical 
to ATP in structure except that it possess a methylene 
group instead of an oxygen atom between theC*and/3 
phosphorous atoms (Figure 1). This analogue can activate 
P2 -purinoceptors in the same way as does ATP, but unlike
21
Figure 1
The phosphorous atoms of the triphosphate moiety of 
ATP are designated The replacement of these
indicated oxygen atoms by methylene residues yields 
ATP analogues like ,^-methylene ATP and ^ ,3- 
methylene ATP.
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ATP it does not initiate synthesis of prostaglandins. 
K a s a k o v  a n d  B u r n s t o c k  (1983) u s e d  m A T P  as a 
desensitising agent for P 2 ~purinoceptors to show the 
presence of a purinergic component in nerve mediated 
responses of the guinea pig urinary bladder.
Enrin.es in  CQr t r ansmission
Burn and Rand (1965) were the first to propose that 
more than one chemical neurotransmitter could be present 
in a nerve, by suggesting that acetylcholine was present 
in adrenergic neurones and was involved in the release 
of NA from the nerve terminal. Until then the view was 
held that nerve cells synthesized and stored only one 
transmitter. This view, known as 'Dale's Principle' 
(Eccles, 1976) stated that " all branches of the neurone 
should have the same chemical transmitter" ( Nothnagal 
lecture, 1934). This concept has now been re-examined by 
applying the term 'transmitter' to any substance that is 
synthesised and stored in nerve cells, is released 
d u r i n g  n e rve a c t i v i t y  and w h o s e  i n t e r a c t i o n  w i t h  
specific receptors on the post-synaptic effector leads 
to changes in post-synaptic activity. This has led to a 
v a r i e t y  of s u b s t a n c e s  b e i n g  i d e n t i f i e d  as 
neurotransmitters including ATP hence leading to a
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breakdown of the original idea of neurotransmission 
being identified as either adrenergic (releasing NA) or 
c h o l i n e r g i c  (releasing A C h ) . A d v a n c i n g  f r o m  this 
plurality of transmission, it is also possible to see 
how more than one substance may be released from a nerve 
by considering that other substances may be released 
together with the principle transmitter by exocytosis of 
vesicle contents at the nerve terminals. For example, in 
adrenergic nerves, NA is stored with chromogranin A, 
dopamine B-hydroxylase and ATP (Smith, 1972).
W i t h  the d e v e l o p m e n t  of immunocytochemistry, 
several biologically active peptides have now also been 
c o n s i d e r e d  as c o - t r a n s m i t t e r s  a l o n g s i d e  the m o r e 
established neurotransmitters like ACh, NA and 5-HT 
(Burnstock, 1982).
H o w e v e r  in the m a i n  it has been ATP that has 
a t t r a c t e d  the m o s t  a t t e n t i o n  as a p o s s i b l e  c o ­
transmitter. ATP has been shown to be both stored and 
released from adrenal chromaffin cells (Douglas & 
Poisner, 1966? Douglas, 1968; Stevens et al, 1972) and 
indications are that it is released alongside NA in 
adrenergic neurones (Su et al, 1971). Recent studies 
agree with these preliminary findings by showing a 
release of [^H]-adenosine and NA caused by K+-induced 
stimulation of rabbit aorta and portal vein (Su, 1975? 
1978). Release and storage of purines has also been 
detected from adrenergic nerves in guinea-pig vas
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deferens (Westfall et al, 1978; Fedan et al, 1981).
However these neuronally released purines are not 
found in some sympathetic nerves like in the spleen 
(Sjarne et al, 1970; Langercrantz, 1976) and those
purines that have been detected in other areas have been 
found to be e x c l u s i v e l y  of p o s t - s y n a p t i c  o r i g i n  
(Fredholm, 1976; Fredholm & Hedquist, 1978; Fredholm & 
Hjemdahl, 1979; Luchelli-Fortis et al, 1979).
The direct pressor response to stimulation of the 
sympathetic outflow in the pithed rat can only be 
partially blocked by reserpine or alpha-adrenoceptor 
antagonists (Grant et al, 1985) suggesting that NA is 
not the only transmitter involved in this response. 
However it can be completely blocked by pre-treatment 
w it h 6 -OHDA suggesting that only nerves possessing 
uptake and accumulation sites for phenylethanolamines 
are involved (Flavahan et al, 1985). This would indicate 
that the entire response arises from adrenergic nerves 
but part of it does not require NA, i n d i c a t i n g  a 
possible role for a co-transmitter. This study also 
indicated that ATP may be involved in the transmission 
process since the P 2 ~purinoceptor desensitising agent, 
mATP, slightly attenuates the response but only in the 
presence of alpha-adrenoceptor antagonists.
Langer and Pinto (1976) suggested that the large 
non-adrenergic non-cholinergic (NANC) response in the
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cat nictitating membrane which persisted after reserpine 
pre-treatment may be due to release of ATP remaining in 
the adrenergic nerves. In the vas deferens, the first 
phase of the bi-phasic response to nerve stimulation is 
resistant to alpha-adrenergic blockade and to pre­
treatment by reserpine (Ambache & Zar, 1971; Gillespie & 
McGrath, 1974? Brown et al, 1983), but was greatly 
reduced by guanethidine (Burnstock & Holman, 1964) and 
6 - OH DA (Fedan et al, 1981). The initial component has 
now also been shown to be antagonised by the specific 
ATP antagonist ANAPP^ (Fedan et al, 1981) and by the 
desensitising agent mATP (Meldrum, 1984? Cunnane & 
McGrath, unpublished work).
Purineroic Neur-Qins^ ulation
Much controversy surrounds the actual definition of 
'neurotransmitter1, therefore whether ATP and related 
purines are classed as principal neurotransmitters, co­
t r a n s m i t t e r s  or n e u r o m o d u l a t o r s  d e p ends on this 
definition. If a neurotransmitter is a substance that is 
synthesized and stored in nerves, released during nerve 
activity, and if its interaction with specific receptors 
in the post-synaptic membrane leads to changes in post- 
synaptic activity, then ATP is a neurotransmitter. 
H o w e v e r  if that s u b s t a n c e  is pr e s e n t  in very low 
concentrations and plays a minor 'modulating* role, that 
substance has been termed neuromodulator rather than 
neurotransmitter.
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A neuromodulator can act on either prejunctional 
receptors to alter transmitter release, or can act 
postjunctionally to modify the action of the principle 
neurotransmitter on the effector cell. The concept of 
prejunctional neuromodulation by activation of pre- 
synaptic receptors has been widely reviewed (see Starke, 
1972; Langer, 1974; Westfall, 1977; Vizi, 1979; and 
Gillespie, 1980). Among the substances suggested as 
neuromodulators are the purines (Vizi, 1979; Clanachan, 
1979; Stone, 1981; B u r n s t o c k ,  1982a). M o d u l a t o r y  
actions of purines reported so far include that on ACh 
r e lease f r o m  the s k e l e t a l  n e u r o m u s c u l a r  j u n c t i o n  
(Ginsborg & Hirst, 1972; Riberio & Walker, 1975) and 
from autonomic nerve endings (Vizi & Knoll, 1976) as 
well as on NA release in a variety of tissues (Paton,
1981). These presynaptic effects are thought to be 
mediated via P^-purinoceptors on the basis of higher 
a d e n o s i n e  p o t e n c y  and p r e f e r e n t i a l  a n t a g o n i s m  by 
theophylline (Clanachan et al, 1977; Vizi & Knoll, 1976; 
Ribero & Dominquez, 197 8 ).
S u g g e s t e d  m e c h a n i s m s  of action of purinergic 
modulation include altering the inflow of Ca^+ to the 
effector cell (Hoick & Marks, 1978; Ribero, 1979; Dowdle 
& Maske, 1980) or by changing receptor sensitivity to 
the principal neurotransmitter whether it be NA or ACh 
(Buchthal & Kahlson, 1944; Ewald, 1976a,b; Nakanishi & 
Takeda, 1973; Hedquist & Fredholm, 1976; Hoick & Marks,
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1978; Kazic & Milosavljevic, 1981; Krishnamurty & 
Kadowitz, 1982).
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INTRODUCTION: PART ii
NANC Transmission In the Luna
NANC innervation has now been reported in a wide 
variety of tissues and organ systems including the 
respiratory tract. The smooth muscle of the lungs and 
airways is innervated by excitatory cholinergic and 
inhibitory adrenergic nerves as well as having a large 
NANC inhibitory component. The first example of NANC 
nerves associated with the airways was reported in the 
guinea-pig trachea (Coburn & Tomita, 1973; Coleman & 
Levy, 1974). This showed that while a small part of the 
relaxatory response obtained by stimulating the trachea 
by field stimulation was attenuated by adrenergic 
blockade, the major neural inhibitory pathway was 
neither adrenergic nor cholinergic. Subsequent reports 
of N A N C  i n n e r v a t i o n  of a i r w a y s  of other species  
followed. In man these are of particular importance 
since there is no direct adrenergic innervation of 
airway smooth muscle in humans (Barnes, 1984) unlike 
other species such as the guinea-pig (Coburn & Tomita,
1973) .
The neurotransmitter associated with the lung NANC 
inhibitory system has yet to be identified but several 
candidates have been proposed. It was thought that the 
existence of purinergic nerves in the airways was 
unlikely since antagonists used to block purine effects 
did not block the NANC inhibitory effects (Irvin et al,
1982). However due to the lack of specific purinergic 
antagonists used in these studies, it was still not
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possible to totally rule out purinergic involvement.
Since these p r e l i m i n a r y  i n v e s t i g a t i o n s  w e r e  
n e g a t i v e  t o w a r d s  the p u r i n e r g i c  p r o p o s a l  of 
neurotransmission, other possible neurotransmitters were 
investigated. Neuropeptides were presented as convincing 
candidates for neurotransmitters since they can be 
localised to nerves in the respiratory tract (Polak & 
Bloom, 1986). The f o r e r u nn e r  in this c a t e g o r y  is 
vasoactive intestinal peptide (VIP). As well as airways 
having a rich VIPergic innervation (Polak & Bloom, 1986; 
Laitinen et al, 1985), VIP is the most potent relaxant 
of human bronchi in vitro (Palmer et al, 1986) even 
although there are very little or no peripheral effects. 
Other evidence against the possibility of VIP being the 
n e u r o t r a n s m i t t e r  a s s o c i a t e d  w i t h  the lung NAN C  
inhibitory system came with the reports that NANC 
i n h i b i t o r y  e f f e c t s  still occur after e x p o s u r e  to 
maximally effective concentrations of VIP (Karlsson & 
Persson, 1984).
In a d d i t i o n  to an i n h i b i t o r y  N A N C  s y s t e m  
experimental investigations also indicate an excitatory 
system in the tracheobronchial tree, which is neither 
cholinergic nor adrenergic (Grundstrom & Andersson,
1983). Peptides such as substance P are thought to be 
the neurotransmitters of these nerves (Lundberg et al,
1984) .
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Therefore to simply say that the lungs and airways 
have an adrenergic, a cholinergic and a third NANC 
system is perhaps an oversimplification. It is likely 
t h a t  s e v e r a l  d i f f e r e n t  t y p e s  of n e r v e s  a n d  
neurotransmitters (or co-transmitters) are involved.
As more specific antagonists become available the 
nature of a neurotransmitter is further elucidated. For 
example, we now have available, 8 -phenyl theophylline 
(8 -PT) for Pj-purinoceptors (Griffith et al, 1981) and 
otjS-me t hy l  e n e  A T P  (mATP) for d e s e n s i t i s i n g  P 2 - 
p u r i n o c e p t o r s  (Delbro et al, 1985), thus e n a b l i n g  
further investigation of possible purinergic involvement 
in the lung NANC system to be carried out.
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Aims £f .the pxe.s.ent study
The aims of this study were to isolate and identify 
non-adrenergic non-cholinergic (NANC) responses in 
different organ systems and in particular to study the 
NANC component in sympathetic vasopressor responses.
In s t u d y i n g  the s y m p a t h e t i c  nerve m e d i a t e d  
vasopressor response it is necessary to characterise all 
the components of the response, both alpha-adrenergic as 
well as NANC components. After identification of the 
components of the vasopressor response, conditions for 
studying the NANC nerve mediated component can be 
optimised.
The study of the alpha-adrenergic component of 
pressor responses to sympathetic nerve stimulation 
requires an investigation of pressor responses to alpha- 
adrenergic agonists in vivo. In so doing a comparison 
between species can be made. This is dealt with in the 
first section of this thesis.
The second section investigates the fractions of 
alpha v e r s u s  n o n - a l p h a  c o m p o n e n t s  of v a s o p r e s s o r  
responses as assessed in the pithed rat preparation: a 
preparation which gives the advantages of working in 
v iv o  w i t h o u t  the d i s a d v a n t a g e s  a s s o c i a t e d  w i t h  
anaesthetised animals such as the involvement of 
autonomic reflexes which would complicate interpretation
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of results. The pithed preparation is particularly 
useful in allowing selective stimulation from the spinal 
column.
By moving the pithing rod electrode up and down the 
spinal column it is possible to find optimum areas for 
stimulation of individual organ systems. This allows 
study of contractile responses to stimulation of the 
sympathetic supply to the vas deferens in the rat as 
well as of the pressor and depressor responses. A study 
of the depressor responses is covered in Section 3 of 
this thesis.
The final section examines the NANC component 
present in the respiratory system. The innervation of 
the lungs and a i r w a y s  c o n s i s t s  of three neuronal  
components: the cholinergic, the noradrenergic , and the 
NANC inhibitory component. In the cat as well as in man, 
this NANC system appears to provide the major inhibitory 
neural input to airway smooth muscle. For this reason 
the experimental investigations were performed in the 
cat. The neurotransmitter associated with the lung NANC 
inhibitory system has yet to be identified, but several 
candidates have been proposed including adenosine and 
adenine nucleotides. In an attempt to characterise this, 
this study employed two purinoceptor blockers, mATP for 
P2 “ purinoceptors, and 8 -phenyl theophylline (8 -PT) for 
Pj-purinoceptors.
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METHODS
■The Pithed Pahbit Preparation
Pithed rats and rabbits were used to examine and 
c o m p a r e  the a l p h a 2 " a d r e n o c e p t o r - m e d i a t e d  p r e s s o r  
responses between two species. This study served to 
extend previously documented in vitro comparative 
studies between these species. The protocol followed for 
the pithed rabbit was similar to that first used by 
McGrath and MacKenzie (1977).
Adult male New Zealand white rabbits of between 3 
and 4 kg were pretreated with atropine (lmg/kg i.p.) and 
anaesthesia was induced by introducing althesin (2 ml/kg) 
into the marginal ear vein. The body temperature of the 
rabbit was maintained at 3 8 ° c throughout the experiment 
by p l a c i n g  the a n i m a l  on a h o m e o t h e r m i c  blanket 
regulated by a rectal probe thermistor.
The a n a e s t h e s i a  i n d uced by a l t h e s i n  l a s t e d 
approximately 5 minutes and allowed a mask supplying 
halothane to be placed on the animal without causing 
distress, which can lead to breath holding. Another 
advantage in inducing anaesthesia by this method is 
that it a l l o w e d  the p o t e n t i a l l y  irritant gaseous  
anaesthetic halothane to be given in a much lower 
concentration than would be possible without pretreating 
w i t h  althesin. A n a e s t h e s i a  is c o n t i n u e d  w i t h  2% 
halothane in a mixture of 1  volume oxygen to 2  volumes 
nitrous oxide.
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Tracheal intubation was performed on disappearance 
of withdrawal reflexes and a double vagotomy carried out 
thereafter. The left carotid artery was cannulated for 
administration of propranolol and the right carotid 
artery cannulated for continuous recording of blood 
pressure via an Elcomatic pressure transducer (EM 
750/752) and monitoring of heart rate with a devices 
instantaneous rate meter (model 4522). The right jugular 
vein was also cannulated for administration of all other 
drugs.
After the animal was turned to the prone position 
and the head secured in a restrainer, the animal was 
connected to a respiration pump and anaesthesia was 
c o n t i n u e d  a t  2 % h a l o t h a n e  in 1 0 0 % o x y g e n .  
Hyperventilation at 50 breaths per minute reduced 
arterial PCC^r which leads to a reduction in brain 
volume and also depresses spontaneous breathing allowing 
uncomplicated mechanical ventilation. The anaesthetic 
levels were adjusted to give a steady blood pressure 
recording of approximately 30mmHg (diastolic) and 
6 0 m m H g  (systolic). This low B.P. level m i n i m i s e s  
bleeding on decerebration but is sufficiently high to 
allow for the large drop in blood pressure which follows 
pithing.
A trephine hole (1.5cm) was drilled through the 
s k u l l  a n d  e n l a r g e d  by b o n e  n i b b l e r s  a l l o w i n g
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d e c e r e b r a t i o n  by s u c t i o n  to be c a r r i e d  out. 
Decerebration was performed whilst holding the vertebral 
arteries, so reducing the amount of blood flow to the 
brain. Following decerebration the skull cavity was 
lined with oxycell and packed with swabs and sterospon 
to reduce bleeding and blood pressure was allowed to 
stabilise at 50mmHg (diastolic) and lOOmmHg (systolic) 
by removing anaesthetic and ventilating with 1 0 0 % oxygen 
(25 b.p.m./ 50ml).
Gallamine (lOmg/kg) was administered intravenously 
to prevent skeletal twitching during pithing. After 
removal of the swabs the rabbit was pithed through the 
trephine hole and the skull was repacked with swabs 
(Figure 2). The pithing rod used was a stainless steel 
rod of 2 mm in diameter.
Since blood pressure measurements were recorded 
throughout the experiment it was possible to observe the 
effects of pithing on arterial blood pressure. The 
e f f e c t s  w e r e  t w o - fold: a large incr e a s e  in blood
pressure due to release of catecholamines from the 
sympathetic outflow (106±llmmHg diastolic, 160±13mmHg 
systolic); and a secondary drop in blood pressure due to 
removal of sympathetic tone on the vasculature. The 
blood pressure remained at this low level (17.0±8.2mmHg 
diastolic, 50±4.5mmHg systolic) (n=10).
Artificial ventilation was continued and parameters
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Fjguig 2
Stimulation of the sympathetic outflow in the 
pithed rabbit preparation is via the pithing rod 
electrode, which is inserted through a trephine 
hole. For selective stimulation of the outflows the 
pithing rod is partly co v e r e d  in tef l o n  for 
insulation.
Hole in skull
Pithing rod
Electrode 
(sympathetic outflow)
changed to 30 breaths per minute, stroke volume 50ml. 
Monitoring blood gas tensions from blood samples taken 
from the preparation showed that these ventilatory 
parameters were sufficient to maintain normal blood gas 
values.
Administration of noradrenaline (NA ) (up to 5 i.v. 
boluses of ljug/kg) immediately after completion of 
pithing improved the viability of the preparation, as 
well as serving as a sensitisation schedule for NA, 
before starting the agonist dose response curves.
The Pithed Rat Preparation
M a l e  W i s t a r  rats (240-260g) w e r e  i n i t a l l y  
anaesthetised in a box with 4% halothane in a mixture of 
1 volume oxygen to 2  volumes nitrous oxide which was 
reduced to 2 % halothane and fed to the rat through a 
mask in the same volumes of oxygen and nitrous oxide on 
disappearance of withdrawal reflexes. After tracheal 
intubation the rats were pithed by the method first 
employed by Gillespie and Muir (1967) and further 
developed by Gillespie, MacLaren and Pollok (1970). This 
involved the insertion of the pithing rod assembly 
(Figure 3 & 4) consisting of a short steel tube (13 
s.w.g.) or trochar which was introduced through the 
orbit and advanced through the foramen magnum to lie at 
the sixth cervical vertebra. Through this was pushed a
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Figure 3.
Rats were pithed via the orbit, the pithing rod 
then served as an e l e c t r o d e  for selective 
stimulation of the spinal outflow. Blood pressure 
and heart rate was monitored from the left carotid 
artery and bolus i n j e c t i o n s  of d r u g s  were 
introduced via the left jugular vein.
Orbit
i 7/J\
Vascular system
}Monitor BP and HRLeft carotid artery
Left 1
jugular > Bolus injection of drug
vein
m
Stimulating electrode
X-ray of a pithed rat showing the pithing rod 
electrode and position of outflows C^r C-j, and
STEEL TUBE'
CERVICAL
THORACIC
narrow steel rod, coated in teflon tubing, down the 
spinal column as far as the lower lumbar region to 
complete the pithing. In experiments where the spinal 
sympathetic outflow was stimulated, the inner rod was 
e x t e n d e d  1 cm beyond the teflon and a cted as an 
electrode.
Immediately after pithing, the rats were ventilated 
using a Harvard rodent ventilator (model 680) with a 40% 
oxygen/60% nitrogen mixture (Grant, 1985) at 60b.p.m. 
and a stroke v o l u m e  of 1ml per lOOg body w e i g h t  
(Clanachan & McGrath, 1976). It was essential that 
artificial ventilation should commence as soon as 
possible after pithing since the respiratory centre had 
been destroyed as a result of pithing.
The maintenance of body temperature was also 
important since control of this was also lost after 
pithing. The temperature of the rats was monitored by 
using a rectal thermometer and maintained at 37°C by 
placing an anglepoise lamp over the animal.
C a r otid  arterial blood p r e s s u r e  w a s  reco r d e d  
continuously from a heparinised cannula inserted into 
the carotid artery by an Elcomatic pressure transducer 
(EM 750/752). Heart rate was recorded with a Devices 
instantaneous rate meter (model 4522) triggered by the 
arterial pulse. Drugs were administered via a cannula 
inserted into a jugular vein at fixed volumes of lml/kg
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washed in by the same volume of 0.9% saline.
The recording device used to display the blood 
pressure and heart rate was a U.V. oscillograph (SE 3006 
DL) .
Sympathetic .N.ec.y_£ Stimulation from .the Spinal QutfLow 
r-Sti.mula.tiQn n£ vasopre s sor nerves...
In experiments where the spinal sympathetic outflow 
was stimulated, the 1 cm exposed tip of the pithing rod 
was used as an electrode. The arrangement of the pithing 
rod is outlined in Figure 3. It is possible to move the 
pithing rod with its 1 cm exposed tip to positions up and 
down the spinal column in order to selectively stimulate 
various organ systems (Figure 5). For example the vas 
deferens can be selectively stimulated at T-j^  - Lj 
(McGrath, 1973), anococcygeus at T-q - L 3  and Lg - S2  
(McGrath,1973), and vasopressor nerves at most points in 
the region Cg - S2 .
An indifferent electrode (silver plate 15cm by 6 mm) 
was placed subcutaneously parallel to and extending the 
full length of the spinal column to limit current 
spread.
The sympathetic outlow was stimulated using a Grass 
S8 8  stimulator or a Square One Instruments stimulator at
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Figure 5
This representation of a pithed rat 
optimum positions for stimulation of 
organ systems including the vas 
anococcygeus, adrenals and vasculature.
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a supramaximal voltage of 40v and pulse width 0.05ms for 
lsec and at a range of frequencies of 1 -20 Hz. Although 
the pulse width employed produced minimal skeletal 
m u s c l e  t w itching, g a l l a m i n e  w a s  a d d e d  in som e  
e x p e r i m e n t s  to ab o l i s h  any i n t e r f e r e n c e  on the 
recordings which were due to experimental artefact.
The pithing rod electrode was placed at different 
regions in the spinal column and vasopressor responses 
were assessed by diastolic pressure changes since 
s y s t o l i c  m e a s u r e m e n t s  are a f f e c t e d  by c a r d i a c  
sympathetic responses, in particular when the electrode 
was placed Cg - T 2 where maximal cardioaccelerator 
responses are obtained (Docherty & McGrath, 1979).
The effects of various antagonists (alpha^, alpha2  
and b e t a - a d r e n o c e p t o r  a n t a g o n i s t s  as w e l l  as 
purinoceptor antagonists) on the diastolic pressure 
changes at various areas of sympathetic spinal outflow 
and at different frequencies were examined. This study 
was also extended to examine the depressor responses 
obtained on stimulating the spinal outflow at regions L5
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Sympathetic Jtexve .Stimulation fioro the Spinal Outflow 
z^timulation p£ ihe xas deferens.
Changes in longitudinal isometric tension of the 
vas deferens to nerve stimulation from the spinal 
outflow and by field stimulation were measured in some 
experiments.
In these experiments, after pithing and carrying 
out cannulations as described earlier, the abdomen of 
the rat was opened by a mid-line incision from the 
s t e r n u m  to the penis. A bath w a s  then f o r m e d  by 
stitching the skin to a brass ring, and was filled with 
liquid paraffin which kept tissues moist throughout the 
e x p e r i m e n t  as well as l i m i t i n g  c u r rent spread  
(Figure 6 ).
Two parallel ties were placed round the epididymal 
ends of the vasa deferentia which were cleared of 
connective tissue before severing the link between them 
and the epididymis by making an incision between the two 
ties. These freed epididymal ends of the vasa deferentia 
were then tied to isometric tension transducers (Grass 
FT03c) and an initial tension of Ig was applied. The 
linkage was chosen to be broken at the epididymal ends 
of the vasa deferentia rather than at the prostatic ends 
as the nerve and blood supply enter and leave at the 
prostatic end (Sjostrand, 1965).
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Figure £
Photograph of the vasa deferentia in situr set up 
to measure c h a n g e s  in l o n g i t u d i n a l  i s o m e t r i c  
tension. The tissues are kept moist in a bath of 
liquid paraffin.
(From McGrath, 1974).

In the experiments where stimulation was from the 
spinal sympathetic outflow, the pithing rod electrode 
was placed at the region the optimum regions
for vas stimulation (McGrath 1973).
It was also possible to place bipolar electrodes on 
each v a s a  d e f e r e n t i a  a l l o w i n g  r e s p o n s e s  to p o s t ­
junctional to be measured and compared to those obtained 
pre-junctionally by stimulation from the spinal outflow.
The stimulation parameters used in this study were 
5Hz / 40v (supramaximal)/ 0.5ms pulse width/ for 1 sec. 
With this larger pulse width of 0.5ms employed in these 
experiments, compared to that used in experiments 
measuring vasopressor nerve mediated responses, it was 
necessary to administer gallamine (lOmg/kg) to prevent 
skeletal muscle twitching.
The preparation measuring the changes in tension of 
the vas deferens in vivo proved to be a useful assay for 
the action of the P2-purinoceptor antagonist mATP on 
s y m p a t h e t i c  nerve s t i m u l a t i o n  since it a l l o w e d  a 
comparison of its actions on vasopressor mediated 
responses and on the responses of the vas deferens using 
the same time course.
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.Xhe Anaesthetised Cat Preparation
Cats ( 2.7 - 3.1 kg ) starved for 18 hours were 
anaesthetised initially with a 1:2 O2 /N 2 O mixture and 5% 
halothane and were then given O^-chloralose (lOOmg/kg 
i.v.) via a vygon tube inserted into the left femoral 
vein. This dose of <*chloralose maintained anaesthesia 
for the duration of the experiment. Sagatal ( lmg/kg 
i.v.) was administered after surgical preparation in 
order to p r e v e n t  s p o n t a n e o u s  b r e a t h i n g  d u r i n g  
respiratory measurements.
Arterial blood pressure was recorded continuously 
from the right femoral artery with a Bell and Howell 
pressure transducer. Heart rate was recorded with a 
Grass tachograph triggered by the arterial pulse. Drugs 
were administered via a cannula inserted in the right 
jugular vein and advanced to the entrance of the right 
a t r i u m  to ensure their rapid d i s t r i b u t i o n  to the 
pulmonary circulation. 5HT infusions, where performed, 
were administered by continuous infusion into the 
cannulated left femoral vein.
The animals were tracheostomized and artificially 
ventilated on room air at a constant frequency (30 
breaths per minute) and constant volume (2 0 ml/kg) with a 
Palmer Ideal respiration pump (model 16/24). The left
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vagus nerve bundle was isolated, ligated and sectioned 
before being placed on a bipolar platinum electrode. The 
cut va g u s  nerve w a s  kept m oist in a saline pool 
throughout the experiment and was stimulated by a 
Scientific Research Instruments stimulator at the 
optimal parameters for stimulation of 25v, 0 .5 ms pulse 
width at a frequency of 15hz for 30 seconds to initiate 
either bronchoconstriction or bronchodilation according 
to the experimental protocol followed. Body temperature 
was monitored with a rectal thermometer and maintained 
at 3 6 °  to 3 9 °  C by p l a c i n g  the a n i m a l  on a 
thermorequlated operating table.
The right vagus remained intact throughout the experiment.
Airflow was determined by a pneumotachograph
(Fleish 0) c o n n e c t e d  to the tracheal ca n n u l a  and 
measuring the pressure drop across the device with a 
differential pressure transducer (Pioden Type). Tidal 
volume was determined by electrically integrating the 
airflow signal. Transpulmonary pressure was measured 
with another differential pressure transducer (Pioden 
Type) analysing the pressure difference between the 
tracheal pressure (from a side arm of the tracheal 
cannula) and intrapleural pressure (from a metal cannula 
inserted into the intrapleural space at the position of 
the left fifth intercostal space), as show in Figure 7.
Dynamic lung compliance and airway resistance were 
computed according to the method of Amdur and Mead 
(1958). The pressure tending to inflate the lung is the
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F i g u r e  1_
This representation of the cat lung preparation in 
situ, illustrates how airflow is monitored from a 
differential pressure tranducer, which measures the 
difference in air pressure across the Fleisch tube. 
Tidal v o l u m e  is d e t e r m i n e d  by e l e c t r i c a l l y  
integrating the airflow signal. Transpulmonary 
p r e s s u r e  (TPP) is m o n i t o r e d  v i a  a n o t h e r  
differential pressure transducer and measures the 
difference in pressure taken from a side arm of the 
tracheal cannula and from a needle inserted into 
the intrapleural space. The resulting traces of 
signals taken from a Grass Polygraph recorder are 
displayed.
CO =r
■g ^O 0> 
0  1 2 . 
0  
C
CL
O >
=T=f
0 JD CQ
CQ
— I 
TJ
m
V  <  
3 I
T3 ^  
Q
transpulmonary pressure (TPP) and comprises an elastic 
component (which relates to the elastic recoil of the 
lungs) and a flow- resistive component (which relates to 
resistance to flow of gas in the lungs and airways and 
to viscous resistance of the lung tissue).
The elastic and flow-resistive components can be 
evaluated separately using specific points during the 
respiratory cycle (Figure 4:2). At points of equal 
volume in the respiratory cycle, the elastic forces 
should be approximately equal, therefore the pressure 
change o b s e r v e d  at this point must be related to 
resistance to flow in the lung and airways. Resistance 
can thus be calculated.
Resistance (cm H2 O/1/sec) = change in pressure
change in flow
Any changes in resistance usually reflect changes 
in the upper airways (ie. constriction of larger airways 
makes a bigger difference to the flow signal than 
constriction in the smaller lower airways).
Bronchoconstriction is usually reflected by an 
increase in resistance and a decrease in compliance. If
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no increase in resistance is observed then we can say 
that the agent causing the bronchoconstriction must be 
acting in the lower peripheral airways.
To calculate compliance (a measure of elasticity) 
(Figure 4:2), pressure is measured at points at the 
beginning and at the end of inspiration when the flow- 
resistive component drops out (ie. no air being moved in 
or out), then at this point
Dynamic lung compliance (mls/cm H2 0 )= Tidal volume
Change in pressure
Changes in compliance relate to changes in lower 
airways, alveoli and in pulmonary circulation etc. Hence 
compounds such as 5HT, that on bronchoconstriction cause 
an increase in resistance and a decrease in compliance, 
we can then say that it affects both lower and upper 
airways.
Blood Gas Analysis
Arterial blood samples (0.2ml) were extracted from 
the carotid arterial cannula into a heparinised syringe, 
kept airtight and directly inserted into the blood gas 
a n a l y s e r  IL 213 (for the rabbits and rats) and 
Radiometer ABL3 (for the cats) to measure blood gas
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tensions. Blood was sampled both at the beginning and at 
the end of most experiments (except in the cases of the 
cat and rabbit experiments, where samples were taken 
approximately every 2 0  minutes) to see if the arterial 
blood gas tension had altered during the experiment. For 
the pithed animals no difference was noted but in the 
anaesthetised cats which were bronchoconstricted by 
infusing 5HT, constant monitoring was required and 
c o r r e c t i o n s  w e r e  made to H C O 3 - levels w h e n  the 
preparation tended towards acidosis.
Physiological arterial blood gas tensions (values 
of approximately pH 7.38 / Pa CO2  40 mmHg/ Pa 100 mmHg) 
were obtained in the pithed rat by ventilating at a rate 
of 60 strokes per min. and at a volume of 1ml per lOOg 
body weight per stroke (or 600ml/kg/min) (Clanachan & 
McGrath, 1976). The ventilatory parameters used in the 
pithed rabbit to attain these values were 30 strokes per 
min and a volume of 50ml (approximately 15ml/kg) per 
stroke (or 450ml/kg/min). For the anaesthetised cat the 
parameters used were 30 strokes per min and a volume of 
2 0 ml/kg per stroke (or 600ml/kg/min). When used in the 
cat with low resting airway smooth muscle tone ( i.e. 
be f o r e  5 HT infusions) these p a r a m e t e r s  p r o d u c e d  
physiological blood gas tensions within the normal 
range.
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statistics
The means and standard error of the means for the 
groups of experiments contained in this study, were 
calculated and the means were compared using a paired 
Student's t-test (Macintosh software 1 Statswork1)• P 
values of 0.05 or less were considered to be significant 
and marked on a scale comprising * to *** , where,
* = P < 0.05
** = 0.001 < P <0.01
*** = P < 0.001
n is the n u m b e r  of p r e p a r a t i o n s  refered to in a 
particular study.
Drugs
The following drugs were used in this study :
Acetylcholine bromide (Sigma), Adenosine 5'-triphosphate 
(ATP) (Sigma), Althesin (Glaxo), Angiotensin I (Sigma), 
Angiotensin II (hypertensin) (Ciba), Atropine sulphate 
(B.D.H.), Captopril (Squibb), 2-Chloroadenosine (2- 
ChlAd) (Sigma), Dipyridamole (Boeringer Ingelheim), 
Enalapril (MK-421) (Merck Sharp & Dohme), Flurbiprofen 
(Boots), G a l l a m i n e  T r i e t h i o d i d e  (Flaxedil) (May &
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Baker), Halothane (Fluothane) (ICI), 5-hydroxytryptamine 
c r e a t i n e  sulphate (5-HT) (Sigma), oCrp -  M e t h y l e n e  
adenosine 5 '-triphosphate (m ATP) (Sigma), Nifedipine 
(Bayer), Noradrenaline (L-arterenol bitartrate) (NA) 
( S i g m a ) ,  P h e n t o l a m i n e  m e s y l a t e  (Ciba), 8 - 
Phenyltheophylline (8 -PT) (Calbiochem), Prazosin HC1
(Pfizer), Propranolol HC1 (Sigma), Rauwolscine (Roth), 
S a r a l a s i n  ([s a r 1 ,ala8 ] - a n g i o t e n s i n  II) (Sigma), 
Teprotide (SQ 20,881) (Squibb), UK 14304 tartrate (5- 
bromo- 6 -[2-imidazolin-2-ylamino]-quinoxaline) (Pfizer) , 
Wy 267 03 (N-methyl-N-(1,3,4,6 ,7,lib -hexahydro-2H-benzo- 
[a]-quinolizin-2 -yl)-i-butanesulphonamide HC1 (Wyeth).
All drugs were dissolved in 0.9% saline except 
flurbiprofen, mATP, prazosin, and rauwolscine which were 
all d i s s o l v e d  in d i s t i l l e d  water. N i f e d i p i n e  was 
dissolved in PEG and ethanol (1:4) and 8 -PT in PEG and 
Na OH, before being diluted down in distilled water.
All drug concentrations are expressed in terms of 
the salt.
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Introduction
Recently it has been suggested that the alpha 2 ~ 
adrenoceptor sub-type may have different pharmacological 
properties in different species (Nahorski .al, 1985; 
Waterfall air 1985? Alabaster air 1 9 8 5 r 1986). 
For example the pre-junctional alpha2 ~adrenoceptors in 
vas d e f e r e n s  of rat and rabbit had a d i f f e r e n t  
antagonist potency series, yohimbine being more potent 
than Wy 26703 in the rabbit but less potent in the rat. 
It was subsequently found that that the potency of each 
antagonist at post-junctional alpha2-adrenoceptors in 
the rabbit saphenous vein was similar to that found at 
the pre-junctional alpha2-adrenoceptors in rabbit vas 
deferens (Alabaster al, 1986).
A c o m p a r i s o n  of the p o s t - j u n c t i o n a l  a l p h a 2 - 
adrenoceptors which mediate pressor responses was 
carried out in the pithed rat and rabbit since this type 
of preparation has been used extensively in the basic 
classification and investigation of alpha-adrenoceptor 
sub-types (Drew & Whiting, 1979; Docherty & McGrath, 
1980). In order to keep conditions as similar as 
possible between the two species, the physiological 
agonist noradrenaline was employed in the presence of 
the alpha^-adrenoceptor antagonist prazosin. The 
effects of rauwolscine and Wy 26703 were then compared.
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When comparing properties of alpha2 ~adrenoceptors 
in the vasculature of rat and rabbit, dose/diastolic 
carotid arterial pressor response curves to NA were 
constructed. The alpha2 “adrenoceptor mediated response 
was isolated by the addition of prazosin ( 1  mg/kg) which 
blocked the alpha^-adrenoceptor mediated response of NA. 
The e f f ects of 2 a l p h a 2 ~ a d r e n o c e p t o r  antagonists, 
rauwolscine and Wy 26703, on the alpha 2 ~ a(3 renoceptor 
mediated response, were tested in each species.
Results
Control experiments
(i) Rabbit. In an earlier study of the pithed 
rabbit (McGrath & Mackenzie, 1977) it was demonstrated 
that the ca r d i a c  output, heart rate, p e r i p h e r a l  
resistance and arterial blood pressure remained constant 
over a 6  hour period during which reproducible responses 
to a variety of reversible agonists and to sympathetic 
nerve stimulation were obtained. In the present study 
a short series of three experiments was carried out in 
w h i c h  d o s e - r e s p o n s e  curves to n o r a d r e n a l i n e  w e r e  
repeated 8  to 10 times over a 5 to 6  hour period and it 
was found that responses were reproducible. In the 
protocol for the first series of experiments (results in 
figures 1 : 1  and 1 :2 ) four consecutive dose/response 
curves to noradrenaline were carried out to ensure
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viability of the preparation and reproducibility before 
testing the effects of antagonists. In the second set 
of experiments (results in figures 1:3 and 1:4) a single 
control curve was obtained before proceeding to examine 
the effects of antagonists.
(ii) Rat. In the pithed rat, four consecutive 
dose/response curves to noradrenaline were obtained. 
In contrast to the rabbit, in which the relatively small 
additions to plasma volume had no effect on the resting 
cardiovascular system, in the rat the diastolic blood 
pressure remained relatively constant but the pulse 
pressure increased throughout the experiment. This was 
presumably due to an increase in plasma volume and hence 
an increase in cardiac output. However, this had no 
s i g n i f i c a n t  effect on the pressor responses to 
n o r a d r e n a l i n e  m e a s u r e d  as increases in d i a s t o l i c 
pressure.
On the basis of these control experiments it is 
reasonable to assume that shifts in dose/response curves 
produced by antagonists reflect the action of the 
a n t a g o n i s t s  and not t i m e - r e l a t e d  d e c r e a s e s  in 
sensitivity of the preparations.
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In the pithed rabbit-
.a.d£.£Il.QC.£Ph.Qj: .and to s^iDp^th^tic u ^ x ^ e
stimulation
Noradrenaline in the range 10ng/kg-l^ug/kg produced dose 
related pressor responses in the pithed rabbit (Figure 
l:la&b & Figure l:3c&d).
P r a z o s i n  (10^ug/kg-l mg/kg) , given on its own, 
produced a dose-related rightward shift in the NA 
dose/response curve. Figure 1:1a shows this for 
prazosin (1 mg/kg). This shift was not parallel and 
r e s u l t e d  in a s h a l l o w e r  g r a d i e n t  for the N A  
dose/response curve, i.e. prazosin was more effective at 
higher doses of NA than at the lower dose range (Figure 
1  :la&b).
Rauwolscine (lOOpg/kg-lmg/kg) (Figure l:la&b) or 
imiloxan (lOmg/kg) (Fig.l:2a&b) given on their own, 
produced small rightward shifts of the NA dose/response 
curve. Rauwolscine was more potent than imiloxan and 
shifted the curve further. Given after prazosin (Img/kg) 
each of these alpha2 _a(3 renocePtor antagonists produced a 
further rightward shift, greater than in the absence of 
prazosin. Combined alpha^- and alpha 2 “ adrenoceptor 
blockade caused a parallel rightward shift in the dose- 
response curve.
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FIGURE 1:1
The effects of sequential a d m i n i s t r a t i o n  of 
antagonists on pressor responses in the pithed 
rabbit to a) noradrenaline b) noradrenaline on an 
expanded scale c) phenylephrine and d) sympathetic 
nerve stimulation (T8 , 20 pulses, via the pithing 
rod) .
Propranolol lmg/kg was present throughout. Control 
responses (V) were obtained and repeated after 
prazosin then 3 increasing doses of rauwolscine 
(left panels) or rauwolscine then prazosin (right 
panels). S y m b o l s  i n d i c a t e  the l a s t  d r u g  
administered.
Prazosin lmg/kg ▲
O  
□
Rauwolscine lmg/kg ^
Responses are shown as mean + standard error of the 
mean. I—bars are omitted where these are smaller 
than the symbols or, in (b) , for clarity, r\-fa
Rauwolscine 100^ug/kg 
Rauwolscine 30(lug/kg
120-i Noradrenaline
100-
a DBP
mmHg
50-
30-j Noradrenaline
(to larger scale)
a DBP 20- 
mmHg
1 0 -
V — V'
lOO-i Phenylephrine
50-
tAgonlst) pg/kg
50-,
a DBP
mmHg 25-
10Hz1.0Hz0.1Hz 10Hz1 .OHz0.1Hz
Freoue.icy
FIGURE lj_2
The effects of seque n t i a l  a d m i n i s t r a t i o n  of 
antagonists on pressor responses in the pithed 
rabbit to a) noradrenaline b) noradrenaline on an 
e x p a n d e d  s c a l e  and c) s y m p a t h e t i c  n e r v e  
stimulation via the pithing rod (1cm electrode, T8 , 
2 0  pulses).
Propranolol lmg/kg was present throughout. Control 
responses (v) were obtained and repeated after a 
sequence of 3 increasing doses of imiloxan at 
concentrations of lmg/kg (not shown), 3mg/kg (not 
shown) and finally lOmg/kg (as shown).
Prazosin lmg/kg A
Rauwolscine lmg/kg y
Imiloxan lOmg/kg &
Responses are shown as mean ± standard error of the 
mean. I-bars are omitted where these are smaller 
than the symbols or, in (b), for clarity. n = G
120-1 Noradrenaline
100-4
50 t\
Noradrenaline 
(to larger scale)
20 H
a  DBP 
mmHg
1 0 H
[NA] /jg/kg
70 i Nerve
50-4
a  DBP 
mmHg 4 — £
25-4
10Hz1 .OHz0.1Hz
Frequency of stimulation
P h e n y le p h r in e  produced dose-related pressor responses in
shifted the dose-response curve to phenylephrine to the 
right. Subsequent addition of rauwolscine (0.1 and 0.3 
mg/kg) had no effect and rauwolscine ( 1  mg/kg) produced 
only a further small shift to the right. Rauwolscine 
given on its own had no effect on the phenylephrine 
d o s e - r e s p o n s e  curve and had no i n f luence on the 
effectiveness of prazosin.
G u a n a b e n z  (1 kg-3 0 Oyug/kg) produced dose-related 
p r e s s o r  r e s p o n s e s  ( F i g u r e  1:5a). R a u w o l s c i n e  
s i g n i f i c a n t l y  reduced responses to guanabenz but 
tachyphylaxis to guanabenz made accurate assessment of 
blockade impossible.
Pressor nerve stimulation (T8 , 20 pulses, 0.1-10Hz) 
produced frequency related responses which reached a 
p l a t e a u  at 1Hz (Figures l:ld & 1:2c). Prazosin, 
rauwolscine and imiloxan were all effective antagonists 
at some point on this frequency-response curve but to 
different degrees at different frequencies. When given 
first, rauwolscine and imiloxan were more effective 
against low frequency nerve stimulation but did not 
reduce responses to higher frequencies. Prazosin was 
effective in reducing responses at both low and high 
frequencies, but b e t w e e n  1Hz and 10Hz a residual 
component remained. The combination of prazosin and
the range (Figure 1:1c). Prazosin
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rauwolscine, or, imiloxan with rauwolscine and prazosin 
(each at lmg/kg), produced a greater inhibition than did 
prazosin alone but did not produce a complete block.
Angiotensin 11 (All) and Angiotensin 1 (AI) at ]
and 1 0  produced dose related pressor responses in
the rabbit. To investigate whether endogenous All is 
necessary for the production of the response mediated by 
a l p h a 2 " a(3 r e n o c eptors, the effects of a n g i o t e n s i n  
converting enzyme inhibitors (ACE-inhibitors) on the 
pressor responses to agonists in the pithed rabbit were 
also studied in a small number of preparations. Results 
w i t h  ena l o p r i l  are s h o w n  in Figure 1:7. The ACE- 
inhibitors teprotide, captopril and enalapril (each at 
0.lmg/kg) all reduced the pressor response to AI
unaffected by any of the ACE-inhibitors, as were the 
late phases of these responses. In the pithed rat, peak 
responses to NA also were unaffected at this dose of 
teprotide. However the late phase of the NA response 
was significantly reduced (Grant & McGrath, 1984).
(lOOng/kg-lOjug/kg), the alphaj-adrenoceptor a 
phenylephrine (100ng/kg-3Oyug/kg) and to the a 
adrenoceptor agonist UK14304 (lpg/kg-3 Ojug/kg)
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Prazosin (lmg/kg) in the rat produced a parallel 
rightward shift in the NA dose/response curve (Figure 
1:3 a & b). In the rabbit, prazosin (lmg/kg) produced a 
greater inhibition against higher doses of NA than 
a g a i n s t  l o w e r  doses, thus le a v i n g  a s h a l l o w e r  
dose/response curve to NA (Figure 1:3c & d).
In either species (Figure 1:3) given after 
prazosin, rauwolscine and Wy 26703 produced a further 
r i g h t w a r d  shift. For Wy 26703 the shifts w e r e  
approximately parallel. In the rabbit, rauwolscine 
produced a greater inhibition against lower doses of NA 
than against higher doses. In the rat, the higher doses 
of rauwolscine (3mg/kg) tended to reduce the slope of 
the curve i n d icating a no n - s p e c i f i c  action of 
rauwolscine. At these doses, no significant pressor 
responses were produced by the antagonists.
These shifts were expressed as dose ratios (the 
dose of NA required to produce a standard response in 
the presence of the alpha2-adrenoceptor antagonist as 
well as prazosin, divided by the dose of NA required to 
produce the same response in the presence of prazosin 
only). Dose ratios w e r e  m e a s u r e d  at changes in 
diastolic blood pressure (DBP) of between 10 and 60 
mmHg. For the illustration of alpha2-adrenoceptor
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FIGURE 1:3
The effects of sequential a d m i n i s t r a t i o n  of 
blocking agents on the NA pressor/response curve in 
the pithed rat (a&b) and pithed rabbit (c&d). For 
this figure log dose-response curves were drawn as 
in Figures 1:1 and 1:2 for individual rabbits and 
the doses to produce responses o.f various sizes 
from 10 to 60mmHg were interpolated. The means of 
the doses for each response were then plotted with 
their s.e.m.s. I-bars are omitted where these are 
smaller than the symbols. U=S
Order of administration Key
1)Propranolol lmg/kg Y
2 )Prazosin lmg/kg v
4)Rauwolscine lmg/kg g  or Wy 26703 lmg/kg □
3)Rauwolscine
5)Rauwolscine 3mg/kg A or Wy 26703 3mg/kg A
Log 
[NA] 
pg/kg
a DBP mmHg
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antagonist potency the graph of dose ratio against 
alpha2 -adrenoceptor antagonist concentration at a change 
in diastolic blood pressure of 10 mmHg showed the 
greatest shift, indicating that at these lower pressor 
changes the alpha 2 -adrenoceptor-mediated component 
dominates.
At a change in DBP of 10 m m H g  (Figure 1:4a) 
absolute antagonist potency and order of potency were 
found to differ b e t w e e n  the species. In the rat 
rauwolscine and Wy 267 03 were equipotent. In the rabbit 
rauwolscine was more potent than Wy 26703. Rauwolscine 
was more potent in the rabbit than in the rat. Wy 26703
was more potent in the rat than in the rabbit (Results
were analysed by Student's paired t-test and results 
with p>0.05 were considered to be non-significant).
At 20 mmHg change in DBP (Figure 1:4b) rauwolscine 
and W y 26703 were still equipotent in the rat. In the 
rabbit rauwolscine was again more potent than Wy 26703. 
The order of potency of antagonists was the same as that 
found at a change in DBP of 10 mmHg.
At 30 mmHg change in DBP (Figure 1:4c) rauwolscine
was more potent than Wy 26703 in both species. At lower
antagonist concentrations rauwolscine was more potent in 
the rabbit than in the rat, but at higher concentrations 
rauwolscine was more potent in the rat. Wy 26703 was 
more potent in the rat than in the rabbit.
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FIGURE ill
Log. d o s e  r a t i o  a g a i n s t  1 o g . [a n t a g o n i s t ] 
illustrating antagonist potency at changes in DBP 
of a) 10 mmHg b) 20mmHg c) 30 mmHg and d) 60mmHg.
Rauwolscine in rat— #--or rabbit- 
Wy 267 03 in rat O o r  rabbit- -O—
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At 60 mmHg change in DBP (Figure l:4d) rauwolscine 
again, was more potent than Wy 26703 in both species. 
Both antagonists were more potent in the rat than in the 
rabbit. It seems that in the rabbit high doses of NA 
produce responses characterised by a relatively low 
dose-ratio to alpha2-adrenoceptor antagonists.
nsssnnsss ms&latnd by xlpJiXi- 
adrenoceptors and alp ha 2 -.ai3x_exP£.ep_tQrs jfcp selective 
■aganists in two species.
Alpha l-adrenoceptor.s
In the rabbit, the alphaj-adrenoceptor agonist 
phenylephrine (Figure 1:1c) in the range lOOng/kg- 
30jug/kg produced dose-related but short lived pressor 
responses giving peak responses comparable to those 
found with NA as the agonist (Figure 1:1a), although the 
NA response was longer lasting.
In the rat (Figure 1:5), the pressor effects of 
phenylephrine were found to be very short lived in 
comparison with those of NA, but were of a comparable 
height. In both species prazosin (lmg/kg) produced a 
large shift in the phenylephrine dose/response curve 
while the alpha2-adrenoceptor antagonist, rauwolscine
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FIGURE 1:5
P r e s s o r  r e s p o n s e s  to a) g u a n a b e n z  a n d  b) 
phenylephrine in the pithed rat and rabbit in the 
presence of propranolol (lmg/kg). n=S
a) O  “ guanabenz in the rat; 0  - guanabenz in the 
rabbit
b) a  - phenylephrine in the rat (with rauwolscine 
lmg/kg ▲  )
□  - p h e n y l e p h r i n e  in the r a b b i t  ( w i t h  
rauwolscine lmg/kg ■  )
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FIGURE 1:6
The effects of sequential a d m i n i s t r a t i o n  of 
antagonists on pressor responses in the pithed 
rabbit to sympathetic nerve stimulation (T8 , 20 
pulses, via the pithing rod).
Propranolol lmg/kg was present throughout. Control 
responses (y ) were obtained and repeated after 3 
i n c r e a s i n g  d o s e s  of p r a z o s i n  f o l l o w e d  by
rauwolscine (panel A) or r a u w o l s c i n e  then 3 
increasing doses of prazosin (Panel b). Symbols 
indicate the last drug administered.
Prazosin lOOyug/kg •
Prazosin 300jug/kg ■
Prazosin lmg/kg ±
Rauwolscine lmg/kg a
Responses are shown as mean + standard error or the 
mean. I-bars are omitted where these are smaller 
than the symbols. n=t>
A  DBP  
mmHg
A  DBP  
mmHg
Nerve
25 H
0.1Hz 1.0Hz 10Hz
50-.
25 H
10Hz1.0Hz0.1Hz
(lmg/kg) left the responses virtually unaltered.
Phenylephrine was 3 times more potent in the rat 
than in the rabbit when measuring control peak pressor 
responses. This ratio is similar to that of NA after 
alpha2-adrenoceptor blockade (Table 1:1).
Alpha 2-adrenoceptors
In the rabbit, the alpha2-adrenoceptor agonist 
guanabenz (Figure 1:5a) in the range lyug/kg-3 OO^ig/kg 
produced dose-related diastolic pressor responses. 
Another alpha2-adrenoceptor agonist, UK14304, produced 
dose related pressor effects which reached a similar 
plateau of 60mmHg at lOOpg/kg (Figure 1:7).
In the rat, guanabenz (Figure 1:5) within the range 
1  0 0 n g / k  g - 1  0 Ojug/k gpr odu ce d d o s e - r e l a t e d  pressor  
responses. Guanabenz was twice as potent in the rat than 
in the rabbit (Table 1:1).
The alpha2-adrenoceptor potency of NA is assessed 
as responses after lmg/kg prazosin, as illustrated in 
Table 1:1, and was 25 times more potent in the rat.
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The effect of the ACE-inhibitor enalapril 
(0 .lmg/kg) and sequentially a d m i n i s t e r e d  
alpha^ - a n t a g o n i s t  prazosin ( l m g / k g ) , on 
vasopressor responses p r o d u c e d  by: Ang I 
(l^ig/kg); Ang II (l-10jig/kg); NA (1-lO^ug/kg); 
phenylephrine (l-10yig/kg); and UK 14304 (3-
pithed rabbit.
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Table 1:1
RAT RABBIT RATIO
RABBIT/RAT
ED20 NA (t t l ) 0.3 |ig/kg 7.0 (ig/kg 23.8
ED20 PE 1.0 (J.g/kg 3.0 (J-g/kg 3.0
Molar ratio
of e d 20 n a /p e 0.47 3.6
’
ED2q NA (a2) 0.3 fxg/kg 7.0 (ig/kg 25.0
ED2q Guanabenz 10.0 jig/kg 20.0 (ig/kg • 2.0
Molar ratio 
of ED2q n a /g 0.04 05
Molar ratio
of ED20 NA (a-, )/NA (a2) 1.0 1.0
The p otency of a l p h a - a d r e n e r g i c  ag o ni s t s  (phenylephrine (PE), 
guanabenz, NA in the p r e s e n c e  of either p r az o si n  (NA (0C 2 ))or 
rauwolscine (NA (o^)) ) in the pithed rat and rabbit measured in
the pr e se n ce  of p r o p r a n o l o l  (lmg/kg). E D 20 v a lues are the
dos es  of the a g o n i s t  r e q u i r e d  to p r o d u c e  changes in d i a s t o l i c  
blood pressure of 20 mmHg. Figures are given in /ig/kg.
Table V I
RAT RABBIT
RATIO
RABBIT/RAT
Rauw. 0.3 0.03 0.1
Wy26703 0.4 1.2 3
RATIO
Wy/Rauw. 1.3 40
The p ot e nc y  of the a l p h a2 a n t a go n is t s r a u w o l s c i n e  and W y  26703 
measured at a change in diastolic blood pressure of lOmmHg, w h er e  
p o t e n c y  is taken as the dose of a n t a g o n i s t  (mg/kg)
required to give a 5 fold shift in the NA dose-response curve. In 
the r a bb i t r a u w o l s c i n e  is 10 t i mes m o r e  potent than in the rat, 
w h e r e a s  in the rat Wy 26703 is 3 t i me s  m o r e  p o t e n t  than in the 
rabbi t .
SECTION II
AN INVESTIGATION OF PURIN.ERGIC OOzTRANSNISSION IN 
VASCULAR CONTROL AND IN TEE VAS P EPEBENfi 
MOTOR RESPONSE,.
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Introduction
It has been proposed that cotransmission involving 
adrenergic and purinergic elements may occur in some 
vascular smooth muscle (Burnstock and Sneddon,1984) and 
further evidence for this phenomenon has since been 
r e p o r t e d  in vitro (Byrne & Large, 1986). There is 
evidence suggesting that this occurs also in vivo. In 
the pithed rat, the P2 ~purinoceptor desensitising agent, 
mATP attenuated pressor responses to sympathetic nerve 
stimulation after blockade of alpha receptors but not in 
the a b s e n c e  of a l p h a - b l o c k a d e  (Flavahan et al, 
1985;Grant et al, 1985). This seemed to suggest a 
relatively minor role for purinergic co-transmission in 
rat vasculature.
In the present study the rats were pithed under 
halothane anaesthesia, were artificially ventilated with 
40% oxygen and 60% nitrogen and were given gallamine 
(lOmg/kg,i.v.) to stop skeletal muscle twitching and 
propranolol (lmg/kg, i.v.) to eliminate vasodilation due 
to catecholamines released from the adrenal medulla 
( ' e n d o g e n o u s  a d r e n a l i n e  reversal'). Drugs w e r e  
administered via the right external jugular vein. Right 
carotid arterial blood pressure and heart rate, derived 
e l e c t r o n i c a l l y  from this signal, w e r e  m o n i t o r e d  
continuously. Diastolic pressor responses to sympathetic 
nerve stimulation via the pithing rod (1 cm electrode,T6 - 
T8,lsec,l-20Hz) were measured.
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Results
RSSEONSESt,
Eferv.e mediated pressor responses
Stimulation of the spinal sympathetic outflow (T^ " 
L 4) via the pithing rod electrode (1 cm tip exposure) 
evoked pressor responses. The size and shape of these 
responses depended on position of stimulation. The 
largest and most reproducible vasopressor responses with 
minimal cardioaccelerator effects were obtained when the 
pithing rod electrode tip was positioned between Tg and 
t 8 (Figure 1:5 & 2:1) but stimulation of any area within 
the region T^- L 4  produced pressor responses. The 
vasopressor responses were frequency dependent (Figure 
2:2). F l a v a h a n  et al (1985) showed that w h e n  the 
stimulating electrode is placed between regions T^ and 
L4 r the resulting pressor response is biphasic and 
comprises a direct pressor component and a delayed 
pressor component due to stimulation of the adrenals.
Noradrenaline
The intravenous administration of NA (lOng/kg - 
lmg/kg) resulted in biphasic pressor responses (Figure 
2:3). The pressor responses were dose dependent (Figure
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Figurg 2 LL
Vasopressor responses obtained to stimulation at 
different spinal positions at 20Hz frequency, 
0.05ms pulse width, 40v, 1 cm electrode, for lsec. 
n- 4-8
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Responses (changes in diastolic blood pressure) to 
stimulation of the sympathetic spinal outflow 
between regions Tg - Tg at frequencies 1 - 20Hz, 
for 1  sec, were measured in: control conditions 
(propranolol (lmg/kg) & gallamine (lOmg/kg) (Q)); in 
t h e  p r e s e n c e  of p r a z o s i n  ( 0 . 1  m g / k  g (♦ ) , 
0 .3mg/kg(B) ,and l m g / k g ^ )  ) and in the presence of 
rauwolscine (lmg/kg(»)). The antagonists were added 
sequentially. n=4.
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Arterial blood pressure recording from a pithed rat 
showing pressor responses obtained to intravenous 
administration of:
A) NA (0.3ug/kg) A
B) olj^  -methylene ATP (0.05mg/kg)O
Imin 
lOsec
Arterial blood pressure (mmHg)
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1:3) were antagonised by prazosin, rauwolscine or Wy 
26703, and were abolished by a combination of alpha^ and 
alpha2-adrenoceptor antagonists.
AdgnQsing and atp
The i n t r a v e n o u s  a d m i n i s t r a t i o n  of a d e n o s i n e  
(100^ig/kg - lOmg/kg) or ATP (l^ug/kg - lmg/kg) produced 
depressor responses (Figure 2:4). Responses to lO^ug/kg 
adenosine and lOug/kg ATP were blocked by the Pj- 
purinoceptor antagonist 8 PT (lOmg/kg).
In one out of four preparations the intravenous 
administration of ATP produced a biphasic response: the 
first component was small, pressor and subject to 
tachyphylaxis. This was similar to the response observed 
on intra-arterial administration of ATP. The second 
c o m p o n e n t  w a s  d e p r e s s o r  and not s u b j e c t  to 
tachyphylaxis.
Alphar beta-methylene AXE
Unlike adenosine or ATP, the intravenous or intra- 
arterial administration of mATP (O.Olmg/kg - 0.5mg/kg) 
produced large but short lived pressor responses (Figure 
2:3). The first few additions produced pressor responses 
that were biphasic and hence similar in appearance to 
both NA and nerve mediated pressor responses. mATP 
administration always resulted in pressor responses even
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Figure 2\4
Arterial blood pressure recording from a pithed rat 
showing responses obtained to intravenous
a d m i n i s t r a t i o n  of ATP (ljug/kg) and a d e n o s i n e  
(lmg/kg).
Arterial blood pressure 
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w h e n  vascular t o n e  w a s  r a i s e d  by i n f ' u s i n g  KA. S i n c e  m A T P  
r e s p o n s e s  w e r e  s u b j e c t  t o  t a c h y p h y l a x i s ,  i t  w a s  n o t  
possible to construct a dose/response curve in a single 
preparation. Instead a comparison of pressor responses 
to first additions of mATP was made between animals 
(Figure 2:5). Prazosin did not appear to alter these 
responses, w h e r e a s  p r e t r e a t m e n t  w i t h  n i f e d i p i n e  
(0.3mg/kg) resulted in pressor responses to mATP being 
smaller than in controls, although neither antagonist 
altered the biphasic nature of the mATP response.
Effects pi  a n t ago n ists s m  pes-S-sq e responses t o  
stimulation o f spin a l -Sympathetic out flow  w ith in
the e eg inn t6  - t8.
Responses to sympathetic nerve stimulation were 
only partially blocked by the administration of the 
alpha-adrenoceptor antagonists prazosin and rauwolscine 
together (each lmg/kg) (Figure 2:6); approximately 60% 
of the response remained when stimulating the Tg region 
for 1 sec at 20Hz. On their own either prazosin or 
rauwolscine were capable of attenuating both the direct 
component and the secondary indirect pressor component 
at this frequency but each of these antagonists affected 
the time course of the nerve mediated pressor response 
differently. This is shown in figures 2:7 and 2:9.
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Figure, 2j5,
Changes in diastolic blood pressure produced by 
intravenous administration of O.OOlmg/kg mATP; 
O.Olmg/kg mATP; O.Olmg/kg mATP in the presence of 
p r a z o s i n  (lmg/kg); and O.O l m g / k g  m A T P  in the 
presence of nifedipine (0.3mg/kg). All data were  
o b t a i n e d  f r o m  d i f f e r e n t  a n i m a l s  to o v e r c o m e  
problems of tachyphylaxis. n=4 for each column.
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Figure 2j.6
Peak vasopressor responses to sympathetic 
nerve stimulation (T6 -T 8 ) for lsec at 20Hz were 
measured as changes in diastolic blood pressure 
(DBP) in control conditions (in the presence of 
propranolol (lmg/kg) and gallamine (1 0 mg/kg)) and 
after the sequential administration of antagonists; 
prazosin (lmg/kg), rauwolscine (lmg/kg), and a 
desensitising dose of mATP.
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Figure 2jJ
Arterial blood pressure recording from a pithed rat 
showing pressor responses obtained to stimulation 
of the sympathetic spinal outflow#(Tg - Tg, 1cm 
electrode, 0.05ms pulse width, lsec, 20Hz) in: a) 
the absence of any agents; b)after the addition of 
propranolol (lmg/kg); c) after gallamine (1 0 mg/kg)? 
and d) after rauwolscine (lmg/kg).
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Arterial blood pressure recording from a pithed rat 
showing pressor responses obtained to stimulation 
of the sympathetic spinal outflow#(Tg - Tg, 1cm 
electrode, 0.05ms pulse width, lsec, 20Hz) after a) 
guanethidine (lOmg/kg), b)prazosin (lmg/kg), and c) 
rauwolscine (lmg/kg).
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Figure 2 ;9
Arterial blood pressure recordings from two pithed 
rat preparations (I & II) showing pressor responses 
obtained to stimulation of the sympathetic spinal 
outflow (Tg - T q , 1cm electrode, 0.05ms pulse 
width, lsec, 20Hz) : a) in the p r e s e n c e  of
propranolol (lmg/kg) and gallamine (lOmg/kg); and 
b) after prazosin (lmg/kg). Trace II shows a large 
and unexpected attenuation by prazosin (lmg/kg). 
T r a c e  I s h o w s  the m o r e  t y p i c a l  d e g r e e  of 
attenuation produced by prazosin (lmg/kg).
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Propranolol
Following propranolol (lmg/kg)f both the direct 
component and the adrenal component of the pressor 
response were increased (Figure 2:7a). The time course 
of the responses also altered, becoming more prolonged. 
In s u b s e q u e n t  experiments, all p r e p a r a t i o n s  w e r e  
pretreated with propranolol (lmg/kg) to block beta- 
a d r e n o c e p t o r  m e d i a t e d  effects of the r e l e a s e d  
catecholamines.
Gallamine
G a l l a m i n e  (lOmg/kg) was a d m i n i s t e r e d  to the 
preparations after pithing to stop skeletal muscle 
twitching. The intravenous administration of gallamine 
often produced pressor responses. In a few preparations 
the effects of gallamine on the nerve-induced pressor 
responses were monitored. Gallamine did not attenuate 
the vasopressor responses and in some preparations 
i n c r e a s e d  them slightly (Figure 2:7b) as w e l l  as 
smoothing out any experimental artifacts caused by 
electrically induced twitching.
Guanethidine
The addition of guanethidine (lOmg/kg) almost 
completely blocked the direct component of the nerve-
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induced pressor response, whilst leaving the secondary 
i n d i r e c t  (adrenal) c o m p o n e n t  intact. S u b s e q u e n t  
administration of prazosin and rauwolscine blocked the 
adrenal component (Figure 2:8).
Prazosin
The a l p h a ^ - a d r e n o c e p t o r  a n t agonist prazosin, 
attenuated both the direct and indirect components of 
the pressor response (Figure 2:9a&b). The effects of 
p r a z o s i n  w e r e  tested in a n i m a l s  p r e t r e a t e d  w i t h  
propranolol and gallamine. Prazosin at a dose level of 
0 .lmg/kg, significantly reduced both of the components 
of the pressor response at each frequency tested ( 1  - 2 0  
Hz). Higher doses of prazosin at 0.3mg/kg and lmg/kg 
produced no further significant decrease in the pressor 
response (Figure 2:2). These p r a z o s i n - r e s i s t a n t  
components could be further antagonised by the addition 
of the alpha 2 _ adrenoceptor a n t a g o n i s t  r a u w o l s c i n e  
(lmg/kg).
The prazosin-resistant component of the adrenal 
response was abolished by the addition of rauwolscine 
(lmg/kg) (Figure 2:10). However the prazosin-resistant 
component of the direct response was only partially 
a t t e n u a t e d  and w a s  s o m e t i m e s  increased after the 
addition of rauwolscine. This post-junctional antagonism 
was frequency dependent, being more effective at the 
l o w e r  f r e q u e n c i e s  of 1 & 5 Hz. At these l o w e r
69
Figure 2:10
The indirect (adrenal) component of the vasopressor 
responses to sympathetic nerve stimulation (T6-T8) 
for Isec at 20Hz was m e a s u r e d  as c h a n g e s  in 
d i a s t o l i c  b lood p r e s s u r e  ( A D B P )  in c o n t r o l  
conditions (in the presence of propranolol (lmg/kg) 
and gallamine (10mg/kg)) and after the sequential 
administration of antagonists? prazosin (lmg/kg), 
rauwolscine (lmg/kg). nx5
control
prazosin
rauw
10 20 
Frequency (Hz)
frequencies, rauwolscine reduced the height of the 
pressor response as well as the time course, whereas at 
higher frequencies of 10 & 20 Hz, the height of the 
response was quite often increased even although the 
time course of the response was reduced (Figure 2:7b). 
After the addition of prazosin and rauwolscine an alpha- 
blocker resistant component persisted (Figure 2:6).
JRa.uwols.cing
Following propranolol (lmg/kg), the administration 
of rauwolscine (lmg/kg) produced significant attenuation 
of the adrenal component of the vasopressor response 
evoked by sympathetic nerve stimulation from the spinal 
o u t f l o w  (Figure 2:11). The r a u w o l s c i n e - r e s i s t a n t  
component was abolished by the addition of prazosin 
(lmg/kg).
The effect of rauwolscine, on its own, on the 
direct component was frequency-dependent (Figure 2:12). 
At the lower frequencies of 1 & 5 Hz, rauwolscine 
reduced the response both in height and in duration, 
whereas at higher frequencies the effect was seen as a 
shortening of the time course of the direct component 
(returning blood pressure to its previous resting value 
quicker) but only slightly reducing the height of the 
response in some p r e p a r a t i o n s  (Figure 2:7b) and 
increasing it in others. The subsequent administration 
of prazosin significantly attenuated the rauwolscine-
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Figure 2:11
The indirect (adrenal) component of the vasopressor 
responses to sympathetic nerve stimulation (T6 -T 8 ) 
for lsec at 20Hz w a s  m e a s u r e d  as c h a n g e s  in 
d i a s t o l i c  b l o o d  p r e s s u r e  ( A d b p )  in c o ntrol  
conditions (in the presence of propranolol (lmg/kg) 
and gallamine (1 0 mg/kg)) and after the sequential 
administration of antagonists; rauwolscine (lmg/kg) 
then prazosin (lmg/kg).
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Figure 2_l12
The direct component of the vasopressor response to 
sympathetic nerve stimulation (T6 -T 8 ) for lsec at 
20Hz was measured as changes in diastolic blood 
pressure ( a dbp) in control conditions (in the 
presence of propranolol (lmg/kg) and gallamine 
(1 0 mg/kg)) and after the sequential administration 
of antagonists? rauwolscine (lmg/kg) then prazosin 
(lmg/kg). n-S
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resistant component but did not completely abolish it. 
An alpha-blocker resistant component could again be 
uncovered.
mATE
By adopting a novel desensitisation schedule for 
mATP and taking into account the short life of mATP in 
vivo, p r e s s o r  responses due to s y m p a t h e t i c  n erve 
stimulation can be shown to be more sensitive to mATP 
than was previously suggested (Grant et al, 1985).
The i.v. administration of mATP (0.01-0.5mg/kg) 
produced a short-lived pressor response which was 
subject to tachyphylaxis (Figure 2:13). The pressor 
response to the first dose of mA T P  given in each 
experiment, irrespective of dose within the range 
tested, differed from the subsequent pressor responses 
to mATP. The first response was biphasic having an 
immediate transient short-lived pressor effect and a 
second long e r  la s t i n g  pressor phase. It w a s  also 
accompanied by an increase in heart rate. Subsequent 
doses produced a monophasic pressor response equivalent 
to the second phase and did not alter heart rate. After 
d e s e n s i t i s a t i o n  the p r essor responses w e r e  not 
significantly larger than responses to the equivalent 
volume of 0.9% saline.
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Figure 2.; 13
This is a recording of arterial blood pressure 
monitored from the carotid artery and shows the 
effect of intravenous administration of boluses of 
mATP (0.1 mg/kg). The first bolus of mATP produces 
a l a r g e  p r e s s o r  r e s p o n s e  b u t  s u b s e q u e n t  
a d m i n i s t r a t i o n s  of the s a m e  d o s e  s h o w e d  
tachyphylaxis.
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The desensitisation procedure for P2 ~purinoceptors 
in vivo:
An initial single i n t r a venous bolus i n j e c t i o n  of
0.5mg/kg mATP caused heart failure in the rats used in 
four preliminary experiments. Therefore in subsequent 
studies requring the presence of high concentrations of 
mATP, an initial low dose of mATP of 0.05mg/kg was 
introduced to desensitise the heart to this effect of 
mATP. A final concentration of mATP of approximately 
2.5mg/kg was gradually introduced to the rat. The first 
2 b o l u s e s  of m A T P  w e r e  given at a dose level of
0.05mg/kg. This was followed by 5 separate boluses of 
mATP at a dose level of 0.5mg/kg approximately every 60 
seconds. This desensitisation procedure spanned a 7 
minute period.
F o l l o w i n g  c o m p l e t i o n  of the d e s e n s i t i s a t i o n  
schedule for mATP, attenuation of nerve-mediated pressor 
responses occurred in a time dependent manner: maximum 
blockade occurred 1 min after the addition of mATP but 
faded within  1 0  min to a maintained desensitisation 
(Figure 2:14).
In the absence of alpha-adrenoceptor antagonists, 
the d e s e n s i t i s i n g  doses of m A T P  reduced p r e s s o r  
r e s p o n s e s  to s y m p a t h e t i c  nerve s t i m u l a t i o n  to 
approximately 40% of control levels (Figure 2:15).
In the presence of alpha-adrenoceptor antagonists,
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Figure 2:14
This recording of carotid arterial blood 
pressure shows the effect of stimulation (^) of 
the spinal sympathetic outflow (T6 -T 8 ) for 1 sec at 
20Hz, in: a) control conditions (in the presence of 
propranolol (lmg/kg) and gallamine (lOmg/kg) only); 
and b) after a d d i t i o n s  of m A T P  to p r o d u c e  
desensitisation of the P2 ~purinoceptors.
The final addition of mATP (0.1 mg/kg) in the 
desensitising schedule is also indicated on the 
trace (#)•
(■f) (lsec,20H
z) 
m
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Figure 2.;, 15
Peak vasopressor responses to sympathetic 
nerve stimulation (T6 - T 8 ) for 1 sec at 20Hz were 
measured as changes in diastolic blood pressure 
(DBP) (in the a b s e n c e  of a l p h a - a d r e n o c e p t o r  
antagonists); in control conditions (propranolol 
l m g / k g  and g a l l a m i n e  lOmg/kg) and after P 2 - 
purinoceptor desensitising doses of mATP.
(n=5)
*
s u b s e q u e n t  a d d i t i o n s  of mATP w h i c h  gave a final 
concentration of 2.5mg/kg completely blocked the pressor 
responses (Figure 2:6).
Nifedipine
The effect of the slow Ca^+ channel blocking agent, 
nifedipine (0.3mg/kg i.a.) on the vasopressor response 
to stimulation of the spinal outflow between regions T6  
- T 8  was also studied.
At 20Hz frequency, after the administration of the 
alpha-adrenoceptor antagonists prazosin (lmg/kg) and 
rauwolscine (lmg/kg), the intra-arterial administration 
of nifedipine (0.3mg/kg) further attenuated the direct 
component of the pressor response by up to 50%, leaving 
a small pressor response which was approximately 15% of 
control level (Figure 2:16). This was fre q u e n c y  
dependent with nifedipine having its largest effect at 
higher frequencies. The subsequent administration of 
mATP sufficient for desensitising (P2 X~purinoceptors) 
completely blocked the remaining pressor response at 
frequencies of 1 - 10 Hz and left a vasopressor response 
of less than 5mmHg at 20Hz (approximately 6 % of control 
response).
The blocking effect of nifedipine was also seen 
before the a d d i t i o n  of the a l p h a - a d r e n o c e p t o r  
a n t a g o n i s t s  (Figure 2:17a&b, 2:18). S u b sequent
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Figure 2 :16
The effect of nifedipine on alpha-blocked 
v a s o p r e s s o r  r e s p o n s e s  to s t i m u l a t i o n  of the 
sympathetic outflow (T6 -T 8 , for 1 sec at 1 - 20Hz) 
are m e a s u r e d  as ch a n g e s  in d i a s t o l i c  bl o o d  
pressure. Responses were measured after propranolol 
(lmg/kg) ( □ ) ,  then p r a z o s i n  (lmg/kg) ( 4 )r 
rauwolscine (lmg/kg) ( n ) r  nifedipine (0.3mg/kg
i.a.) ($) and finally mATP (■)• n=5
_ D control 
♦ prazosin 
n rauwolscine
°  nifedipine T ^
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Figure 2 :17
Arterial blood pressure recording from a pithed rat 
showing pressor responses obtained to stimulation 
of the sympathetic spinal outflow (Tg - Tg, 1cm 
electrode, 0.05ms pulse width, lsec, 20Hz) : a) in 
the presence of propranolol (lmg/kg) and gallamine 
(lOmg/kg); and b) after nifedipine (^ ) (lmg/kg).
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The eff e c t  of n i f e d i p i n e  on u n b l o c k e d  
v a s o p r e s s o r  res p o n s e s  to s t i m u l a t i o n  of the 
sympathetic outflow (T6 -T 8 , for 1 sec at 1 - 20Hz) 
are m e a s u r e d  as ch a n g e s  in d i a s t o l i c  b lood 
pressure. Responses were measured after propranolol 
(lmg/kg) (a  ), then nifedipine (0.3mg/kg i.a.)
(♦), prazosin (lmg/kg) ( B ) f rauwolscine (lmg/kg) 
($), and finally mATP (■). n-$
AD
BP
 
(m
m
H
g)
Q control 
•  nifedipine 
B praz 
°  raus 
■ mATP
60-
40"
20 -
0 10 20
Frequency (Hz)
administration of prazosin attenuated the response by 
about 60%, indicating that a large alpha-adrenoceptor 
component remains after nifedipine treatment. Using a 
different sequence of administration of antagonists, it 
can be shown that nifedipine has very little effect on 
the vasopressor response after the administration of a
p2x_P ur^noceP^or desensitising dose of mATP (Figure 
2:19). After the addition of mATP and nifedipine, the 
subsequent administration of prazosin (lmg/kg) and 
rauwolscine (lmg/kg) together, almost completely blocked 
the pressor responses at all frequencies.
Teprotide
The angiotensin converting enzyme (ACE) inhibitor, 
teprotide (lmg/kg) attenuated the purinergic component 
of the pressor response (that is, in the presence of 
adrenergic blockers): it significantly reduced the
pressor response that remained after the addition of 
prazosin (lmg/kg) and rauwolscine (lmg/kg) at 20Hz 
stimulation frequency (Figure 2:22).
&  comparison responses Jlq stimiLLatiaa at d iff exeat 
xeqjons the spinal QUtflQ.VL*.
In all three regions studied, T^ - T 4 , Tg - T 3 , and T ^ 2  
™ h j , the percentage contribution of the purinergic 
component (assessed as the percentage of the response 
that remained after adrenergic blockade) to the overall
size of the pressor response was larger than that of the
alpha-adrenergic component of the response (Figure
2:24). In areas - T4  & Tg - Tq, this difference was 
significant.
TJxe Q.L mAT.E pp  £.hp px.e.s.s.QX r e s p onse tp
n-ona-dxenaline*
The effects of the desensitising dose of mATP were 
studied on the pressor responses to 3 doses of NA. 
Single bolus doses of 0.1, 0.3, and 1 yug/kg NA gave
control dose-dependent pressor responses of 20 + 5, 36 + 
8 , and 58 ±  6  mmHg respectively (n = 5, in each case). 
Within 10 minutes after the addition of mATP these same 
3 doses of NA gave pressor responses of 22 ± 6 , 35 ± 8 , 
and 6 0 + 5  mmHg and were not significantly different 
from the control responses. The sequence of the 
additions of the NA doses were alternated in each 
experiment since the blocking effect of mATP is time 
dependent (Figure 2:20).
The effect pf mATP pp vas deferens responses*.
Longitudinal tension of the vasa deferentia were 
recorded in situ (Figure 6 ) by the method employed by 
Gillespie & McGrath (1974). Stimulation of the spinal 
sympathetic outflow from the pithing rod electrode (1 cm 
electrode, T 1 3 r lsec, 5-20 Hz) gave c o n t r a c t i l e  
responses. The effects on these by the sequential
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Figure 2.; 11
The effect of nifedipine on P 2 “ purinoceptor 
desensitised vasopressor responses to stimulation 
of the sympathetic outflow (T6 -T 8 , for 1 sec at 1 - 
2 0 Hz) are measured as changes in diastolic blood 
pressure. Responses were measured after propranolol 
(lmg/kg) (0), then mATP ( 4 ) f nifedipine (0.3mg/kg
i.a.) (□), and finally prazosin (lmg/kg) and
rauwolscine (lmg/kg) together (<>)• ns4*
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Figure ZjIQ.
This graph illustrates the time dependent 
blocking effect of mATP in vivo on agonist induced 
and nerve mediated vasopressor responses (T6 - T 8 , 
for 1 sec at 20Hz) and on nerve mediated motor 
responses of the vas deferens (T13, for 1 sec at 
5Hz). These effects are plotted as % of control 
response of each p r e p a r a t i o n  at t w o  m i n u t e  
intervals after the administrations of mATP.
The vasopressor responses to NA (O.ljug/kg 
(0); 0.3jug/kg (■); lyug/kg (□)) were measured 
immediately after completion of the desensitisation 
s c h e d u l e  for P 2 ~ p u r i n o c e p t o r s  by mATP. Dose 
response curves were completed in each preparation 
but the sequence of administration was rotated to 
take into account the short life of mATP in vivo. 
NA responses were measured in the presence of 
propranolol (lmg/kg).
Vasopressor responses to sympathetic nerve 
stimulation were measured both before (♦) and 
after (E ) alpha-adrenoceptor antagonists had been 
added. Motor responses of the vas deferens were 
measured after alpha-adrenoceptor blockade (D). 
These responses were measured in the presence of 
propranolol (lmg/kg) and gallamine (lmg/kg).n= 4- 6
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administration of propranolol, prazosin, rauwolscine and 
mATP were studied.
Neither propranolol (lmg/kg) nor prazosin (lmg/kg) 
affected the monophasic contractions of the vas deferens 
but rauwolscine (lmg/kg) did increase the responses 
(Figure 2:21).
The effects of mATP on the responses of the vas 
deferens were two-fold. The initial effects observed on 
addition of bolus injections of mATP (0.01- 0.lmg/kg) 
were increases in tone of the muscle accompanied by 
i n c r e a s e s  in c o n t r a c t i o n s  to the s y m p a t h e t i c  
stimulation. Within one minute this potentiating effect 
disappeared and was replaced by an attenuation of the 
responses (Figure 2:21).
This blocking effect of mATP was time dependent. 
These effects are illustrated in Figure 2:20 which shows 
the diminishing blocking effect of mATP on various 
responses with respect to time.
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Figure Z.ill
This trace shows the contractile responses 
obtained by stimulation of the vas deferens of the 
pithed rat in situ (1cm electrode, T13, 40v for 
lsec at 5Hz at 1 minute intervals). Responses were 
measured after the sequential administration of 
propranolol (lmg/kg) (A), prazosin (lmg/kg) (A), 
rauwolscine (lmg/kg) (D)r mATP (O.Olmg/kg) (O) 
and mATP (0.lmg/kg) (•).
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The direct component of the vasopressor response to 
sympathetic nerve stimulation (T6 - T 8 ) for lsec at 
20Hz were measured as changes in diastolic blood 
pressure ( ^ D B P )  in control conditions (in the 
presence of propranolol (lmg/kg) and gallamine 
(1 0 mg/kg)) and after the sequential administration 
of antagonists; prazosin (lmg/kg) & rauwolscine 
(lmg/kg) together, and then after the addition of 
teprotide (lmg/kg). n - 5
control 
+praz&rauw 
+tepr
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Figure 2jl21
T h i s  r e p r e s e n t a t i o n  of s y m p a t h e t i c  
neurotransmission shows how NA and ATP can act as 
co-transmitters. NA activates alpha^- and alpha 2 ~ 
adrenoceptors located on the effector smooth muscle 
cell to operate the receptor operated channels 
(R.O.C.s) as well as decreasing calcium binding. 
Both of these routes result in an increased free 
i n t r a c e l l u l a r  c a l c i u m  c o n c e n t r a c t i o n  since 
activation of ROCs allows calcium entry. This 
concept of having both types of alpha-adrenoceptor 
intra-junctionally has largely superceded the 
suggestion that only the alpha^-adrenoceptor lies 
at the neuroeffector junction with the alpha 2 ” 
adrenoceptor located extra-junctionally. ATP acts 
t h r o u g h  P2~ p u r i n o c e p t o r s  e v o k i n g  e x c i t a t o r y  
junction potentials (e.j.p.s) and opening slow 
calcium channels to propagate action potentials, 
thus leading to contraction of the smooth muscle 
via potential operated channels (POCs) which allow 
calcium entry.
Another proposed mechanism exists but this 
time only one transmitter is released (NA) which 
acts through the alpha^- and alpha 2 “ adrenoceptors 
or through a third type of adrenoceptor termed 
gamma-adrenoceptor. Gamma-adrenoceptor activation 
leads to smooth muscle contraction through the same 
pathway proposed for P2 -purinoceptor activation.
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The percentage contribution of the adrenergic 
versus the purinergic component (the component 
remaining after adrenoceptor blockade) to the 
overall size of the pressor response to stimulation 
of the sympathetic outflow (1cm electrode, 20Hz, 1 
sec, 0.05ms pulse width, 40v) at different regions 
of the spinal outflow (Tx - t4 , T 6  - T8 , and T 1 2  - 
Lj) . n>t
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f f l m  MEDIATED DEPRESSOR RESPONSES
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Electrical stimulation of the spinal outflow in the 
pithed rat preparation produces vasopressor responses 
when the 1 cm electrode tip of the pithing rod lies 
b e t w e e n  the regions C 6  to L5, or w h e n  the full 
sympathetic outflow is stimulated with the whole pithing 
rod as an electrode (Gillespie et a l f 1970). When the 
sacral outflow only is stimulated, the changes in 
systemic arterial blood pressure are depressor (Dusting 
& Rand, 1972; McGrath, 1973) (Figure 1).
Depressor responses (Figure 3:1) were observed when 
the point of stimulation of the spinal outflow was 
b e t w e e n  r e gions L5 and S2. In this region the 
vasopressor responses initiated by sympathetic nerve 
stimulation were either completely absent or were so 
small that the overall effect observed was a decrease in 
blood pressure. These depressor responses were not large 
when viewed against the systemic blood pressure, but 
they wer e  reproducible and distinct. No depressor 
responses were found outside this region. There were no 
accompanying changes in heart rate with the decreases in 
blood pressure.
The stimulatory parameters used to obtain the 
depressor responses were 5 - 2 0  Hz frequency, 0.5ms 
pulse width, 40v, for 1 second. The responses were 
frequency dependent and maximal at 20Hz frequency 
(Figure 3 :2 ) and reached a plateau approximately 1 0  
seconds after the beginning of stimulation. Blood
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pressure returned to the pre-stimulus control level 
between 30 seconds and 3 minutes after nerve stimulation 
had stopped, depending on frequency of stimulation.
Ef-f.ect adrenergic .and cholinergic antagonists
In the absence of any antagonists the depressor 
response obtained at 20Hz was approximately 8.0mmHg. 
A t r o p i n e  (lmg/kg), p r a z o s i n  (lmg/kg), propranolol 
(lmg/kg), and rauwolscine (lmg/kg) given intravenously 
had no effect on the depressor responses either on their 
own or when administered sequentially (Figure 3:3). This 
confirms that these responses are non-adrenergic and 
non-cholinergic (McGrath, 1973; Gardner, 1977; Gardner & 
McGrath, 1978) .
Effect .of guanethidine
In the absence of other antagonists, the adrenergic 
neurone blocking agent guanethidine (lOmg/kg) produced, 
on intravenous bolus injection, a large pressor response 
and accompanying increase in heart rate. These effects 
are due to its indirect sympathomimetic action.
Guanethidine (lOmg/kg) did not attenuate the nerve 
mediated depressor responses and in most cases increased 
the drop in blood pressure caused by nerve stimulation 
( F i g u r e  3:1). In c o n d i t i o n s  of a d r e n e r g i c  a n d  
cholinergic blockade, the subsequent administration of
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Figure 3 ;1
Stimulation of the sacral outflow (L5  - S2 r 20Hz, 
lsec, 0.5ms) produces a depressor response. These 
responses increase in magnitude after the addition 
of guanethidine (•)(lOmg/kg).
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guanethidine (lOmg/kg) did not produce a large pressor 
response since its indirect sympathomimetic action had 
been blocked by the adrenergic antagonists. Again the 
effect of guanethidine was to increase the size of the 
depressor response (Figure 3:4).
Effect q L  gallamine
Gallamine (lOmg/kg i.v.) was added to prevent 
skeletal muscle twitching on stimulation of the spinal 
outflow. In all but 3 out of 18 animals studied, the 
intravenous administration of gallamine (lOmg/kg) did 
not affect the nerve induced depressor responses. In the 
3 animals that were affected by gallamine, no further 
depressor responses were noted in these preparations 
after gallamine addition.
Effect jQf purinergic antagonists
N e i t h e r  the p ^ - p u r i n o c e p t o r  a n t a g o n i s t  8  PT 
(lOmg/kg) nor the P2 ~purinoceptor desensitising agent 
mATP, when administered according to the desensitising 
schedule as discussed previously, had any significant 
effect on the nerve induced depressor responses, when 
used either on their own or in conditions of adrenergic 
and cholinergic blockade (Figure 3:5 & 3:3).
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Figure 3j_2
Stimulation of the sacral outflow (L5  - S2  r lsec, 
0.5ms) in the absence of antagonists, produces 
depressor responses. These responses are frequency 
dependent,as illustrated by plotting the decrease 
in blood pressure produced by nerve stimulation 
(mmHg) against the frequency of stimulation. (n=6 )
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F ig u r e  2_l3.
Stimulation of the sacral outflow (L5  - S2 * 20H z f 
lsec, 0.5ms) produces depressor responses which are 
unaffected by the sequential administration of 
p r a z o s i n  ( l m g / k g ) ,  p r o p r a n o l o l  ( l m g / k g ) ,  
r a u w o l s c i n e  (lmg/kg), a t r o p i n e  (lmg/kg), and 
finally cy,|3-methyene ATP (final concentration of 
2.5mg/kg). (n=5)
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This graph plots the depressor response (mmHg) 
against frequency of stimulation (L5  - S2 r l s e c r 
0.5ms) in control conditions (□)(n=10), after the 
addition of guanethidine (10mg/kg)(^) (n=5) , and 
the eff e c t  of g u a n e t h i d i n e  after a d r e n e r g i c  
blockade (propranolol, prazosin and rauwolscine 
(each at lmg/kg) (n=5)(H).
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Figure 3 »5.
Nerve mediated depressor responses (L5  - S2  r 20 H z f 
lsec, 0.5ms) plotted as the reduction in blood 
pressure (mmHg) is unaffected by the addition of 
8PT(10mg/kg) in c o n d i t i o n s  of a d r e n e r g i c  and 
cholinergic blockade. n = 4 -
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Localisation .of depressor response
The nerves mediating the vasodepressor response 
were found to have a spinal origin from L 5  to S2  and 
w i t h i n  this region w e r e  found to be of the s a m e  
magnitude wherever the electrode was placed. Attempted 
laminectomies in the lower lumbar and upper sacral 
r e g i o n s  w e r e  u n s u c c e s s f u l  in a b o l i s h i n g  the  
vasodepressor responses and therefore a more precise 
localisation of spinal outflow was not achieved.
In determining whether a specific vascular bed was 
innervated by the vasodepressor nerves, the effect of 
occluding the circulation of blood in different areas 
was investigated. This showed that whilst occluding 
blood flow to the hind limbs by ligating the femoral 
arteries had no effect on the depressor response, either 
completely removing the lower gut or occluding its blood 
supply by ligating the abdominal aorta just below the 
renal arteries but above the superior mesenteric artery, 
was successful in completely abolishing the depressor 
responses.
However occlusion of the large vascular bed of the 
gut itself produced a decrease in the resting blood 
pressure which might have masked any nerve-mediated 
depressor responses. The addition of guanethidine
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increased the blood pressure to a level that was higher 
than b e f o r e  m e s e n t e r i c  occlusion. V a s o d e p r e s s o r  
responses did not return with this increase in blood 
pressure resting level.
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The innervation of the lung and airways consists of 
three n e u r o n a l  c o m p o n e n t s :  the c ho l i n e r g i c , the
noradrenergic and the nonadrenergic noncholinergic 
inhibitory component. In the cat, as well as in man, 
this NANC system appears to provide the major inhibitory 
neural input to airways smooth muscle (Barnes, 1986). 
The study of the NANC component was therefore conducted 
in the anaesthetised cat.
When resting bronchial smooth muscle tone is low, 
v a g a l  s t i m u l a t i o n  c a u s e s  a c h o l i n e r g i c  
bronchoconstriction (Schwieler, 1966). However when the 
resting tone is high, stimulation of the vagus causes a 
non-adrenergic non-cholinergic bronchodilation (Diamond 
& O'Donnell, 1980? Irvin et al, 1980).
In the e x p e r i m e n t s  w h e r e  the bronchodilatory 
responses were studied, 5HT was continuously infused (5 
- 2 0  yug/kg/min) into the cannulated left femoral vein to 
increase bronchial tone, by acting directly on the 
bronchial smooth muscle.
A f t e r  t r a c h e a l  i n t u b a t i o n  t h e  c a t s  w e r e  
artificially ventilated on room air and respiratory 
measurements of airflow and transpulmonary pressure were 
made. Figure 4:1 illustrates the parameters measured in 
these experiments. Dynamic lung compliance and airways 
resistance could then be calculated from the resulting 
traces of these signals (Figure 4:2).
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Figure 4 ;1
This is an illustration of the parameters measured 
in these experiments. The top trace is arterial 
blood pressure measured in mmHg. The second trace 
is a measure of transpulmonary pressure (TPP) in 
cm H 2 0. Tidal volume (VT) is also recorded. The 
airflow recording shows the positions of 0  - 
80mls/sec flow corresponding to the expiratory 
part of the respiratory cycle. Time is displayed 
in seconds.
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These traces are lettered according to different 
p o i n t s  in the r e s p i r a t o r y  cycle, e n a b l i n g  
respiratory measurement of dynamic lung compliance 
(Panel I) and airway resistance (Panel II) to be 
calculated.
Compliance is measured at the beginning and end of 
inspiration whe n  no air is being moved in or out 
(ie. no flow). 
cdyn“ Ti^al Volume
Change in Pressure 
On the trace, A - B= the amount of air inspired
C - D= the corresponding change in 
pressure (TPP) during inspiration.
Resistance is calculated at points of equal lung 
v o l u m e  (U & V), w h e r e  e l a s t i c  f o r c e s  are
approximately equal.
Resistance^ Change in Pressure (W - X)
Change in Flow (Y - Z)
On the trace, W & Y lie at the corresponding 
positions in the pressure cycle and flow cycle 
respectively as the point U in the tidal volume. X 
& Z correspond to point V.
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B r o n c h o c o n s t r i c t i o n  and bronchodilation cause 
changes in compliance and resistance. Compliance is a 
measure of the lung elasticity and reflects any changes 
in the lower airways, alveoli and pulmonary circulation. 
Changes in resistance are associated with changes in the 
airflow signal which in turn reflect changes in the 
upper airways. Mean values of TPP levels, resistance 
and compliance readings, for 12 preparations, in low 
resting airway smooth muscle tone and in high resting 
tone (produced by infusing 5HT) are given in Figure 4:3.
Bronchoconstriction can most easily be shown as 
increases in the TPP signal, and bronchodilation as 
decreases. This is because TPP (the pressure tending to 
inflate the lung) comprises both the resistant and 
compliant components. The cholinergic agonist ACh is a 
b r o n c h o c o n s t r i c t i n g  a g e n t  a n d  t h e  i n t r a v e n o u s  
administration of this agonist leads to increases in TPP 
signals (Figure 4:4).
Profiles si agonists on the airways.
produced large reproducible bronchoconstrictions (Figure 
4:4). These responses were dose-dependent (Figure 4:19) 
and were completely blocked by lmg/kg atropine.
I n t r a v e n o u s l y  a d m i n i s t e r e d  A C h  
lOOyug/kg), given either via jugular or femoral veins,
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Figure ,4 i l
M e a n  v a l u e s  (N = 12) of TPP, r e s i s t a n c e  and 
compliance in the artificially respired animal in 
conditions of both low and high resting tone (as 
produced by 5HT infusions).
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The intravenous administration of ACh (20ug/kg) if) 
produces a decrease in the blood pressure and heart 
rate as well as increasing the TPP signal.
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The i nt r a v e n o u s  a d m i n i s t r a t i o n  of a de n o s i n e  
resulted in marked bronchoconstriction (Figures 4:20 & 
4:21). This was slow in onset and long lasting and 
required clamping of the outlet of the respiration pump 
to force open the lungs before beginning to return to 
resting level. This bronchoconstriction was potentiated 
by d i p y r i d a m o l e  (lOmg/kg) (Figure 4:22) and w a s  
antagonised by either 8 PT (lOmg/kg) (Figure 4:22) or 
aminophylline (lOmg/kg). The administration of the 
adenosine analogue 2-Chloroadenosine (lmg/kg) also 
p r o d u c e d  b r o n c h o c o n s t r i c t i o n ,  w h e r e a s  i n osine  (a 
breakdown product of adenosine) at dose levels up to 
lOmg/kg had no effect on the resting levels of TPP, 
resistance or compliance.
Both 8 PT (lOmg/kg) and mATP (0.lmg/kg & 0.5mg/kg) 
c au s e d  i n i t i a l  e v a n e s c e n t  b r o n c h o c o n s t r i c t i o n  
immediately after their administration. The intravenous 
administration of mATP produced bronchoconstriction in 
both low and high tone (Figure 4:23 & 4:24). The 
bronchoconstrictor responses to mATP were subject to 
tachyphylaxis. Another effect noted on administering 
mATP was an increased mucus secretion from the lung.
8 PT produced bronchoconstriction in both low and 
high tone, which was not blocked by aminophylline 
pretreatment. The responses produced by 8 PT were not 
consistent and were sometimes accompanied by decreases 
in blood pressure (Figures 4:25 & 4:26). It was also
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noted in some preparations in conditions of high resting 
tone that additional increases in tone caused by 8PT 
administration (lOmg/kg) led to the onset of spontaneous 
breathing. The PEG/ NaOH vehicle for 8PT administration, 
was tested separately and had no effect on the lung.
Ihs is. &£ £ iiin iil.a ± ljQ u  i i ^ d
bcQnchocpnstriction and bronchodilation.
Stimulation of the vagal nerve bundle at 15Hz/25v 
for 30sec at 0.5ms pulse width resulted in either 
bronchoconstriction (when the airway smooth muscle has 
low resting tone) (Figure 4:5) or bronchodilation (in 
high resting tone) (Figure 4:6).
For the investigation of the NANC component of the 
n e r v e  i n d u c e d  b r o n c h o d i l a t i o n ,  the c e r v i c a l  
v a g o s y m p a t h e t i c  n e r v e  b u n d l e  ( c o n t a i n i n g  both 
sympathetic and parasympathetic nerves) was stimulated 
rather than just the parasympathetic branch (the vagus) 
and alpha and beta adrenoceptor antagonists were added 
to block any adrenergic effects. Phentolamine could not 
be used to block alpha^ and alpha2 ~adrenoceptors since 
it has anti-5HT activity and therefore reduced bronchial 
tone induced by the 5HT infusion. Thus prazosin was used 
to block alpha^-adrenoceptors and either idazoxan or 
p r e t r e a t m e n t  w i t h  r a u w o l s c i n e  to block a l p h a 2 ” 
adrenoceptors.
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Figure .4..;5.
Panel A shows a bronchoconstriction to stimulation 
of the vagus at 15Hz / 25v for 30 seconds (pulse 
width 0.5ms) in conditions of low resting airway 
s m o o t h  m u s c l e  tone and in the p r e s e n c e  of 
propranolol (lmg/kg).
P a n e l  B s h o w s  t h e  r e s p o n s e  a f t e r  t h e  
administration of the p ^ p u r i n o c e p t o r  antagonist 
8PT.
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This bronchodilation was produced by stimulation 
of the vagal bundle at 15Hz for 30 seconds in a 
cat u n d e r g o i n g  5HT i n f u s i o n  to i n c r e a s e the 
b r o n c h i a l  tone. The cat w a s  p r e t r e a t e d  w i t h  
atropine (lmg/kg). No other antagonists were 
present.
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Nerve induced bronchoconstriction in low resting airway 
smooth muscle tone: An invest ig.a.tion cf the cholinergic 
And adrenergic involvement.
Stimulation of the vagus in conditions of low 
resting airway smooth muscle tone and in the absence of 
any antagonists produced bronchoconstriction (Figure 
4:5). The degree of bronchoconstriction produced by 
nerve stimulation is frequency dependent (Figure 4:7) 
a n d  is m a x i m a l  a r o u n d  15 Hz f r e q u e n c y .  T h e s e  
bronchoconstrictory responses are comparable to those 
obtained by intravenous administration of ACh (Figure 
4:4), with respect to time course and susceptibility to 
b l o c k a d e  by a t r o p i n e  (lmg/kg). The nerve i n d u c e d  
bronchoconstriction was not blocked by adrenergic 
antagonists propranolol (lmg/kg), prazosin (lmg/kg) or 
rauwolscine (lmg/kg) but it was significantly enhanced 
after 8PT addition (lOmg/kg) (Figure 4:5).
Nerve induced bronchodilation in high resting -ai.rw.ay 
smooth muscle tone*.
In conditions of high resting airway smooth muscle 
tone produced by infusing 5HT, stimulation of the 
s e c t i o n e d  l e f t  v a g u s  n e r v e  b u n d l e ,  p r o d u c e d  
b r o n c h o d i l a t o r y  r e s p o n s e s  w h i c h  w e r e  f r e q u e n c y  
dependent. M a x i m a l  re s p o n s e s  w e r e  o b t a i n e d  at 
frequencies between 15 and 20 Hz (Figure 4:8). These
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Figure 4 ;7
All 3 graphs are frequency response curves to 
stimulation of the vagal bundle in conditions of 
low resting airway smooth muscle tone and are 
measured as percentage changes in TPP, compliance 
and resistance. Graphs i) and iii) are plotted as
p e r c e n t a g e  i n cr ea s es  in TPP and res i stance,
r e s p e c t i v e l y  and gr a p h ii) as p e r c e n t a g e
decreases in compliance, from the prestimulus
resting levels. (N=4)
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All 3 graphs are frequency response curves to 
stimulation of the vagal bundle in conditions of 
high resting airway smooth muscle tone and are 
measured as percentage changes in TPP, resistance 
and compliance. Graphs i) and ii) are plotted as 
p e r c e n t a g e  d e c r e a s e s  in TPP and resistance, 
r e s p e c t i v e l y  and g r a p h  iii) as p e r c e n t a g e  
increases in compliance, from the prestimulus 
resting levels. (N=4)
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bronchodilatory responses reached their maximum between 
5 and 30 seconds after nerve stimulation had stopped and 
w er e  not r e d uced by su b s e q u e n t  and s e q u e n t i a l  
i n t r a v e n o u s  i n j e c t i on s  of atropine, p ro pr a n o l o l ,  
prazosin and idazoxan, each drug given at a dose levels 
of lmg/kg (Figure 4:9).
An investigation pucinergic involvement in the nerve 
mediated bronchodilator responses.
The P^-purinoceptor antagonist 8PT (lOmg/kg) caused 
a small reduction in the neurally evoked bronchodilatory 
response at 15Hz frequency in the presence of muscarinic 
and alpha and b e t a - a d r e n o c e p t o r  b l o c k a d e  (Figures 
4 :10 ?11; 12; 13). This was shown to be a dose-related 
inhibitory effect on bronchodilation in so far as 8PT at 
a dose level of 3mg/kg had no effect on the response but 
the higher dose of lOmg/kg did have. Following the 
a d m i n i s t r a t i o n  of the ade n o s i n e  uptake i n h i bitor 
dipyridamole (lOmg/kg), it was found that 8PT markedly 
attenuated the bronchodilator response (Figure 4:14) at 
15 Hz w h e n  c o m p a r e d  to 8PT's a t t e n u a t io n bef o r e  
dipyridamole addition. This combined dipyridamole/ 8PT 
attenuating effect was also observed at the submaximal 
f r e q u en cy  of 5Hz (Figures 4:15 & 4:16), but the
bronchodilator response could not be completely blocked 
at either frequency.
Although the addition of dipyridamole (lOmg/kg)
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Figuts 413
The sequential administration of adrenergic and 
cholinergic antagonists had no effect on the 
decreases in TPP and resistance, or increases in 
compliance from the control values for nerve 
i n d u c e d  b r o n c h o d i l a t i o n  r e s p o n s e s  
(15Hz/25v/30sec/0.5ms pulse width) in conditions 
of high resting airway smooth muscle tone. (N=4)
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Figure 4 ;10
Nerve induced bronchodilation responses (15Hz / 
25v / 30sec / 0.5ms pulse width) in the presence 
of a tr o p i n e  ( l m g / k g ) , p r o p r a n o l o l  (lmg/kg) , 
prazosin (lmg/kg) and rauwolscine (lmg/kg), which 
were all administered before the start of 5HT 
i n f u s io n (Panel A); and after 8 PT a d d i t i o n  
(lOmg/kg).
with 
Atr./Prop./Praz./R
auw
.
Figure 4;11
In high resting airway smooth muscle toner the 
change in TPP (cmH20) caused by vagal stimulation 
f r o m the p r e s t i m u l u s  re s t i n g  l evel s h ow s  a 
significant difference when measured before and 
after the addition of 8PT (lOmg/kg) (n=6).
CHANGE in TPP CAUSED by VAGAL STIMULATION from 
PRESTIMULUS RESTING LEVEL
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The percentage changes in TPP, resistance and 
compliance measurements caused by vagal stimulation 
(15 Hz) before and after 8 PT (lOmg/kg) in high 
resting airway smooth muscle tone. (n=6).
Differences in the change in TPP, resistance and 
compliance measurements caused by vagal stimulation 
before and after 8PT (1 Omg/kg). (n=6)
Mean ATPP Mean Aresistance Mean Acompliance
from prestimulus from prestimulus from prestimulus
value value value
Before -41.5% -57.0% +66.0
8PT ±5.7 ±3.2 ± 14.1
After -30.8% -39.5% +42.8%
8PT ±4.5 ±3.9 ±9.2
Significance *0.05 *0.035 0.268
level
Figure 4 ;13
The difference in TPP, resistance and compliance 
values caused by vagal stimulation (15Hz) before 
and after 8 PT (lOmg/kg) in high resting airway 
smooth muscle tone (n=6).
(cf. figure 4:15
* = significantly different from dipyridamole 
treated preparations)
The difference in TPP, resistance and compliance 
values caused by vagal stimulation before and after 
8PT (10mg/kg). (n=6)
TPP
(cm H20 )
Resistance 
(cm H20/l/sec)
Compliance 
(ml/cm H20 )
Before 
8 PT
Prestimulus
value
16.4 + 0.9 157.5 + 21.9 2.94 + 0.29
Poststimulus
value
9.8 + 1.2 66.3 + 6.5 5.04 +0.71
% age of Pre­
stimulus value
58.5% + 5.7 43.0% + 3.2 166.0%+14.1
After
8PT
(10mg/kg)
Prestimulus
value
19.5 + 2.1 174.8 + 29.0 2.60 + 0.39
Poststimulus
value
14.0 ±2.2 109.0 + 22.6 3.80 + 0.80
% age of Pre­
stimulus value
69.2% ± 4.5 
*
60.5% ± 3.9
*
142.8%+9.20 
*
Eiguxe Ail!
The c ha n g e  in TPP ( c m H 2 0) c a us ed  by vagal 
stimulation (15Hz) from the prestimulus resting 
level is measured in single animals in conditions 
of muscarinic and alpha- and beta-adrenergic 
blockade, and in the presence of dipyridamole 
(lOmg/kg) before and after the addition of 8 PT 
(lOmg/kg).
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Figure 4 :15
Differences in the change in TPP, resistance and 
c o m p l i a n c e  m e a s u r e m e n t s  c a u s e d  by v a g a l  
stimulation ( 5 Hz) in conditions of muscarinic and 
alpha- and beta-adrenergic blockade and in the 
presence of dipyridamole (lOmg/kg) before and 
after 8PT (lOmg/kg) (n=4).
(cf. figure 4:13 
* = significant difference)
TPP
(cm H20 )
Resistance 
(cm H20/l/sec)
Compliance 
(ml/cm H20 )
Before 
8 PT
Prestimulus
value
26.3 ±0.9 210.5 ±20.0 8.0 ±0.57
Poststimulus
value
17.2± 1.1 125.0 ±10.7 11.1 ±0.7
% age of Pre­
stimulus value 65.1% ±3.2 59.2% ±8.1 37.7%+ 20.0
After
8PT
(10mg/kg)
Prestimulus
value 28.1 ±2.7 222.1 ±17.0 7.3 ±0.7
Poststimulus
value 22.8 ±3.1 177.3 ±15.0 10.7 ± 1.0
% age of Pre­
stimulus value 82.7% ±2.9 
*
79.6% ±8.0
*
47.2%+15.5
*
Figure 4 :16
The difference in TPP, resistance and compliance 
values caused by vagal stimulation (5Hz) in 
conditions of muscarinic and alpha- and beta- 
a d r e n e r g i c  b l o c k a d e  and in the p r e s e n c e  of 
d i p y r i d a m o l e  (lOmg/kg) b e f o r e  and after 8 PT 
(lOmg/kg) (n=4)-
Mean ATPP 
from prestimulus 
value
Mean Aresistance 
from prestimulus 
value
Mean Acompliance 
from prestimulus
value
-34.9% -40.8% +67.3%
Before
8PT ±_32 + 8.1 + 20.0
After -17.3% -20.4% +52.8%
8PT
+ 15.0+ 2.9 + 8.0
Significance
level
★ ★ n.s.
enhanced the blocking effect of 8PT on the nerve induced 
bronchodilatory response, dipyridamole on its own did 
not affect the bronchodilatory responses using 15Hz 
(maximal frequency stimulation). At the sub-maximal 
frequency of 5Hz dipyridamole increased the duration of 
the response, but did not increase the peak size.
In the presence of adrenergic and cholinergic 
a n t a g o n i s t s ,  another Pj^-purinocept or a n t a g o n i s t  
a m  i n o p h y 1 1 ine ( l O m g / k g ) ,  s l i g h t l y  re d u c e d  the 
b r o n c h o d i l a t o r y  response. The a d m i n i s t r a t i o n  of 
aminophylline was carried out in one preparation to 
s e r v e  as an  a l t e r n a t i v e  to 8 P T  a n d  i t s  
bronchoconstricting effects. The administration of 
aminophylline (lOmg/kg) resulted in a transient decrease 
in the 5HT-induced tone (Figure 4:17).
The P2-purinoceptor desensitising agent mATP, did 
not s i g n i f i c a n t l y  a n t a g o n i s e  the v a g a l l y  i n d u c e d  
bronchodilation either in the presence or in the absence 
of atropine , 8PT and the alpha and beta-adrenoceptor 
antagonists (Figure 4:18).
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Figure 4 ;ll
The i n t r a v e n o u s  a d m i n i s t r a t i o n  of the P^- 
purinoceptor antagonist, aminophylline (10 mg/kg) 
resulted in a transient bronchodilation, when 
airway smooth muscle has high resting tone.
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The difference in TPP, resistance and compliance 
values caused by vagal stimulation (15Hz) in 
conditions of muscarinic and alpha- and beta- 
adrenergic blockade measured before and after mATP 
(2.5mg/kg) (n=5).
Mean ATPP 
from prestimulus 
value
Mean Aresistance 
from prestimulus 
value
Mean Acompliance 
from prestimulus 
value
Before -49.4% -44.4% +79.0%
mATP +4.8 +5.9 ±12.1
After -49.4% -45.4% +72.0%
mATP ±4.7 ±6.1 ±17.1
Significance
level
1.0 0.52 0.21
Figure 4.ill
These graphs are dose/response curves to ACh in 
conditions of low resting airway smooth muscle 
tone (with no a n t a g o n i s t s  present) and are 
measured as percentage changes in TPP, compliance 
and resistance. Graphs i) and ii) are plotted as 
p e r c e n t a g e  i n c r e a s e s  in TPP and resistance, 
r e s p e c t i v e l y  and g r a p h  iii) as p e r c e n t a g e  
decreases in compliance, from the control resting 
levels. (N=4)
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The intravenous administration of Adenosine 
(lOmg/kg) (fO produces a decrease in the blood 
pressure level as well as increasing the TPP 
signal.
TPP (cm H20)
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The i n t r a v e n o u s  a d m i n i s t r a t i o n  of A d e n o s i n e  
(l m g / k g )  p r o d u c e s  a b r o n c h o c o n s t r i c t i o n  
characterised by changes in the TPP (in cm 
resistance (R) (in cm I^O/l/sec), and compliance 
(C) (in ml/ cm H2 0) values.
(n=4)
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The bronchoconstriction produced by intravenous 
a d m i n i s t r a t i o n  of l O m g / k g  adenosine and 
characterised by changes in TPP, resistance and 
compliance, is increased by the administration of 
dipyridamole (lOmg/kg) and antagonised by 8PT 
(lOmg/kg) (n = 4).
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Figure 4 l23.
The intravenous administration of mATP (O.lmg/kg) 
(f) in conditions of low resting airway smooth 
muscle tone produces bronchoconstrictions shown by 
increases in the TPP signal. The blood pressure 
effects varied and were usually depressor, but 
pressor effects were noted in a few preparations.
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The intravenous administration of mATP (O.lmg/kg) 
(^) in high resting airway smooth muscle tone also 
produces bronchoconstrictionsr shown here by the 
small increase in the TPP signal.
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Figure 4 ;,25
The i n t r a v e n o u s  a d m i n i s t r a t i o n  of the P^- 
purinoceptor antagonist 8PT (lOmg/kg) (tO produced 
a la r g e  b r o n c h o c o n s t r i c t i o n  (shown by the 
increased TPP signal). In this preparation the 
bronchoconstriction was accompanied by a decrease 
in systemic arterial blood pressure.
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Figure 4_;2&
The i n t r a v e n o u s  a d m i n i s t r a t i o n  of the P^- 
purinoceptor antagonist 8PT (lOmg/kg) (f) produced 
a large b r o n c h o c o n s t r i c t i o n  (shown by the 
increased TPP signal). In this preparation the 
bronchoconstriction was not accompanied by a 
decrease in systemic arterial blood pressure, 
however an increase in heart rate was observed.

Section I_l Piscussion
The p r e s s o r  e f f e c t s  of c a t e c h o l a m i n e s  or 
s y m p a t h e t i c  nerve s t i m u l a t i o n  in p i t h e d  rats and 
rabbits, can be reduced by either alphaj-adrenoceptor 
antagonists such as prazosin, or by alpha2 “adrenoceptor 
antagonists such as rauwolscine, imiloxan, Wy 26703 or 
yohimbine.
Difficulties can arise when classifying receptors 
by using relative potencies of agonists at producing 
pharmacological effects because the response produced 
depends on affinity, efficacy and on the ability of 
agonists to show tachyphylaxis, as well as on the 
stimulus-response coupling mechanism of the tissue 
involved. It was for this reason that antagonists 
rather than agonists were used in this classification.
However since both alpha^ and alpha2 -adrenoceptors 
are involved in the response the quantitative effects of 
each antagonist depend not only on the dose of NA or 
frequency of nerve stimulation, but also on whether one 
of the receptor sub-types has already been blocked by 
another antagonist. The full effect of either an alpha^ 
or alpha2 selective antagonist is clear only after the 
influence of the other receptor has been removed. Thus 
in the pithed rabbit the addition of rauwolscine alone 
(Figure l:la&b), produced only a small shift in the NA 
dose/response curve, but in the presence of prazosin the 
shift to each dose of rauwolscine was much greater
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i n d i c a t i n g  that a l t h o u g h  both alpha^ and a l p h a 2  
adrenoceptors participate in this pressor response, they 
do not do so by straightforward summation but rather in 
a non-additive way. The dominance of either one of the 
receptors can mask the role of the other receptor.
The rabbit, like the rat, has alpha^- and alpha 2 " 
a d r e n o c e p t o r s  both of w h i c h  can m e d i a t e  p r e s s o r  
r e s p o n s e s  to n o r a d r e n a l i n e  and can be c l a s s i f i e d  
according to antagonist potencies. The selectivity of 
each antagonist, for the alpha-adrenoceptor sub-types in 
the rabbit, was established by its effects against 
phenylephrine. This is similarly shown in the rat. The 
effects of the more selective imiloxan (RS 21361) 
(Michel & W hiting, 1981) c o n f i r m e d  the a l p h a 2 ~ 
adrenoceptor selectivity of rauwolscine and showed that 
the higher doses of r a u w o l s c i n e  had s o m e  a l p ha^-  
adrenoceptor antagonism.
However against low doses of MA, rauwolscine is 
more potent in the rabbit than in the rat, whereas 
Wy 26703 is not (Table 1:2). This is consistent with 
the hypothesis that alpha2-adrenoceptors in rabbit are 
different from those in rat with regard to relative 
antagonist potency and shows that this applies to 
resistance vessels in vivo. We have not analysed the 
alpha^-adrenoceptors in the two species i n  t h e  same w a y  
here. T h e  potency of prazosin against phenylephrine 
(PE) in the rabbit (Figure 1:1c) was s l i g h t l y  l e s s  t h a n .
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was found in the rat under similar conditions (in the 
presence of rauwolscine and propranolol, both at lmg/kg) 
(Flavahan, 1983).
NA was more potent in the rat than in the rabbit at 
either alpha^ or alpha2 "a<3 renoceptors but this was not 
reflected in the potency of the "selective" agonists 
phenylephrine and guanabenz (Table 1:1). This could be 
interpreted as a difference in metabolism or disposition 
of NA between the two species, or this may represent 
another difference between alpha-adrenoceptors in the 
two sp e c i e s  so that both a g onist and a n t a g o n i s t  
potencies differ. Together with the small difference 
in potency of prazosin mentioned above this might extend 
the difference to alpha^-adrenoceptors as well as 
a l p h a 2 “ a d r e n o c e p t o r  s. This has p r e v i o u s l y  been
suggested in isolated aorta by Ruffolo and Waddell 
(1982). However caution is necessary in interpreting 
absolute potency differences under non-equilibrium in 
vivo c o n d i t i o n s  (see D o cherty & Hyland, 1985) 
particularly since some of the newer synthetic alpha2 ~ 
adrenoceptor antagonists have partial agonist activity 
which varies between species (Paciorek & Shepperson, 
1983).
Responses to NA in rabbit have a higher proportion 
mediated by alpha2 _adrenoceptors at l°w doses compared 
with high doses at which alpha^-adrenoceptors become 
dominant. However even at the lower part of the
94
dose/response curve a small shift due to prazosin was 
observed, indicating that even at this level the alpha^ 
component plays some part, although alpha 2 is still 
dominant. A similar phenomenon occurs with pressor nerve 
induced responses which have a relatively greater 
a l p h a 2 “*adr en o c e p t  o r - m e  d i a te d c o m p o n e n t  at l o w  
frequencies of stimulation. This conclusion can be
reached using either rauwolscine or imiloxan as alpha2 ” 
adrenoceptor antagonist.
It is conceivable that other factors, such as 
differences in the way that the two species metabolise 
the agonists or antagonists could contribute to the 
apparent differences in antagonist potencies encountered 
in this study. However this seems unlikely since similar 
species differences in antagonist-ranking are apparent 
in in vitro preparations.
Because of the dual nature of the response parallel 
shifts of dose/response curves to alpha 2 "antagonists 
could not be expected since a proportionally greater 
alphaj component emerged as the size of the response 
increased. Therefore alpha 2 antagonist potency was 
compared between the rat and rabbit using dose ratios, 
which covered different regions of the NA dose/response 
curve: a) the shallow initial part of the curve at
diastolic pressor changes of 10 and 20 mmHg; and b) the 
steeply rising part at changes in diastolic blood 
pressure of 30 and 60 mmHg.
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The p o t e n c i e s  of the a l p h a 2 a n t a g o n i s t s  w e r e  
s t u d i e d  in the p resence of prazosin. The c e n t r a l  
observation was that the order of potencies of the 
alpha 2  antagonists differed between species and this 
difference was characterised by an increase in the 
potency of rauwolscine from rat to rabbit as well as a 
decrease for Wy 26703.
This suggests that the alpha2 ~adrenoceptor involved 
in the pressor response to NA in vivo may be different 
in the rat and rabbit. Other recent investigations 
(Alabaster et al, 1984; Nahorski et al, 1985; and 
W a t e r f a l l  et al, 1985) indicate that the a l p h a 2 ~ 
a d r e n o c e p t o r  may have different p h a r m a c o l o g i c a l  
properties in different species. In vitro in the vas 
deferens, prejunctional alpha 2 receptors of rat and 
rabbit had different antagonist potency series, leading 
to the c o n c l u s i o n  that a l p h a 2  rec e p t o r s  w e r e  a 
heterogenous population with respect to species rather 
than tissue type or location (Alabaster et al, 1984).
Recent work by Schumann & Lues (1983) proposes a 
role for All in the vascular postsynaptic alpha 2 “ 
adrenoceptor-mediated response by showing that All, 
acting postsynaptically, potentiates the contractile 
res p o n s e  of a l p h a 2 ~ a d r e n o c e p t o r  agonists in the 
s a p h e n o u s  v e i n  of the rabbit. H o w e v e r  the 
administration of teprotide, captopril or enalapril to
96
the rabbit did not affect the responses to NA, UK 14304 
or phenylephrine, but did reduce the response to Al by 
80%. Therefore this proposal is not supported by the 
present study.
The results show that components of the response to 
vasopressor nerve stimulation can be partly blocked by 
alpha-adrenoceptor antagonists but that a resistant 
component remains. This indicates both alpha-adrenergic 
and n o n - a l p h a - a d r e n e r g i c  (possibly non-adrenergic) 
components of the vascular excitatory transmission 
process. This was further investigated in this present 
study (Section 2).
Against pressor responses to stimulation of the 
spinal outflow, low doses of prazosin (0.1 and 0.3 
m g / k g ), in the rabbit (Figure 1:6) and in the rat 
(Docherty & McGrath, 1980; Flavahan et al., 1985), 
produced the same degree of blockade as did the higher 
dose of 1 mg/kg. Another a l p h a - a d r e n o c e p t o r
antagonist, corynanthine, was also effective from 0.5 
m g / K g  (Demichel et al., 1982). This s h o w s  that 
responses are susceptible to low doses of alpha-one 
blockers and provides no evidence that the higher dosage 
of prazosin ( 1  mg/kg) produces non-specific effects as 
h a s  b e e n  s u g g e s t e d  by H i r s t  et al ( 1 9 8  5). 
Nevertheless there is a substantial component of the 
v a s o p r e s s o r  r e s p o n s e ,  p a r t i c u l a r l y  at h i g h e r  
frequencies, which in the rabbit as in the rat is
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resistant to alpha-adrenoceptor blockers. In contrast 
the alpha2 ~adrenoceptor-mediated component can be rnggt 
easily demonstrated at low frequencies of stimulation. 
At high frequencies, the pre-junctional activity of the 
a l p h a 2 - a d r e n o c e p t o r  a n t a g o n i s t s  c o m p l i c a t e d  t h e  
interpretation of the nerve mediated pressor response 
data by i n t e r f e r i n g  w i t h  the n e g a t i v e  f e e d b a c k  
mechanisms associated with the neurotransmitter# This 
would result in an increase of transmitter available to 
compete at the post-j unctional receptor sites#
In conclusion, the results are consistent with the 
characteristics of the vascular postjunctional alpbS2 ' 
adrenoceptor being species dependent*
Section II:Discussion
Stimulation of the sympathetic spinal outflow 
between regions Tj and L 4 produced pressor responses, 
whilst stimulation between regions L 5  and S 2  produced 
depressor responses. Responses to different agonists 
(alpha-adrenergic as well as purinergic) were compared 
to those obtained by nerve stimulation.
Vasopressor responses to NA and mATP compared well 
with those obtained on stimulation of the spinal outflow 
between regions T 1 and L 4. mATP, but not ATP, produced 
large pressor responses. This may be because ATP is 
rapidly broken down to adenosine (the intravenous 
a d m i n i s t r a t i o n  of w h i c h  results in v a s o d e p r e s s o r  
responses) and therefore exerts its action via P-^- 
purinoceptors. Depressor responses to ATP and adenosine 
were compared to those obtained by stimulation of the 
spinal outflow between regions L5 and S2 « The responses 
to adenosine and ATP were abolished by 8 PT but the nerve 
mediated vasodepressor responses were unaffected by 8 PT. 
The depressor response to ATP was therefore due to 
breakdown to adenosine and not via its interaction with 
P 2 y“ purinoceptors, which have been shown to produce 
vasodilation in the rabbit mesenteric artery (Burnstock 
& Warland, 1987).
In order to observe the p r o p e r t i e s  of alpha- 
adrenoceptor mediated responses (excitatory), it was 
necessary to block the beta 2 -adrenoceptors present on
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the vascular smooth muscle, (whose activation results in 
vasodilation) by propranolol (lmg/kg). The contribution 
of skeletal muscle was kept to a m i n i m u m  by employing 
low pulse widths (0.05ms) to minimise current spread by 
administering gallamine (lOmg/kg).
The results suggest that the widespread sympathetic 
vasopressor response to stimulation of the sympathetic 
outflow in the rat comprises alpha-adrenergic and 
purinergic elements since it can be partly blocked by 
alpha-adrenoceptor antagonists or by a purinergic P2x 
desensitising agent but can be completely blocked by a 
combination.
On its own, mATP significantly attenuated the 
vasopressor responses to nerve stimulation by about 60% 
of control values. After a combination of alpha^ and 
alpha2 -a<3 renoceptor antagonists, the residual response 
was completely removed by mATP. This blocking effect of 
mATP was deemed to be specific against P2 ~purinoceptors 
since a similar dose level of mATP had no effect on the 
pr e s s o r  responses p r o d u c e d  by the i n t r a v e n o u s  
administration of noradrenaline. Taken together, these 
o b s e r v a t i o n s  su g g e s t  that the r e s p o n s e  to this 
particular stimulus (20 pulses at 20Hz) consists of two 
additive elements, 40% alpha-adrenergic (mainly alpha^) 
and 60% purinergic.
These conclusions contrast with those drawn made in
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a s e p a r a t e d  study in the p i t h e d  rabbit (McGrath, 
unpublished observations), where the alpha-component was 
larger (up to 70% reduction in response after the 
a d d i t i o n  of the a l p h a - a d r e n o c e p t o r  a n t a g o n i s t s  
r a u w o l s c i n e  (lmg/kg) and p r a z o s i n  (lmg/kg). The 
prazosin/rauwolscine resistant component in this case 
could only be slightly attenuated by additions of mATP. 
This might indicate that the rabbit has a very small 
purinergic component in comparison to the rat, which has 
a relatively small alpha-adrenergic component.
The evidence from the study using lmg/kg prazosin, 
shows that the contribution of alpha-adrenoceptors in 
the pressor response to nerve stimulation in the pithed 
rat is in some cases a lot less than the arbitrary value 
of 50% q u o t e d  by Hirst & L e w  (1987), since the 
percentage contribution of adrenergic and purinergic 
c o m p o n e n t s  to the overall r e s p o n s e  d e p e n d s  on 
stimulation parameters and position of stimulation. 
N e v e r t h e l e s s  these v a l u e s  w e r e  larger than those 
reported for an in vivo study of the pressor responses 
in the anaesthetised rabbit (Hirst & Lew, 1987) using 
b e n e x t r a m i n e  (lOmg/kg) as the alpha^-adrenoceptor 
antagonist instead of prazosin.
However the experimental set up used in this study 
was different from that used by Hirst & Lew. The present 
study used a pithed preparation (and hence has a lower 
resting blood pressure) and w a s  s t i m u l a t e d  pre-
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ganglionically at the Tg - Ts outflow. The stimulation 
was therefore to a generalised area. In comparison, 
Hirst & Lew used an anaesthetised model with a higher 
r e s t i n g  b l o o d  p r e s s u r e ,  and s t i m u l a t e d  p o s t -  
ganglionically to the hind limb only.
One further difference between pithed rat and 
anaesthetised rabbit preparations is that the pithed 
rats have increased Angiotensin II/ renin levels (Grant 
1985). This species difference is more apparent when  
comparing the lower resting blood pressure levels of 
pithed rabbits with the higher levels of pithed rats. 
The addition of teprotide inhibited the nerve induced 
pressor response in the pithed rat by up to 30% after 
blockade of alpha-adrenoceptors (Figure 2:22) indicating 
that the non-alpha-mediated pressor response may be 
m o d u l a t e d  by A n g i o t e n s i n  II. Thus d i f f e r e n c e s  in 
percentage contribution of alpha and non-alpha activity 
may be expected to vary between these preparations.
The results therefore demonstrate that stimulation 
of the sympathetic spinal outflow can produce vasopresor 
r e s p o n s e s  that are l a r g e l y  m e d i a t e d  at the P2x~ 
purinoceptor and to a lesser degree by alpha^ and 
alpha2“a(3renoceptors. The relative contribution of these 
components is dependent on both position of stimulation 
and on parameters of stimulation applied, since the 
contribution of the purinergic component varied directly 
with the frequency of stimulation. Burnstock & Warland
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(1987a) also found that in the rabbit saphenous artery 
in vitro, the purinergic component was the dominant 
component. However they concluded from this in vitro 
study that the relative contribution of the purinergic 
component, to the overall contractile response, was 
inversely related to the frequency of stimulation (low 
frequencies favouring the purinergic component of the 
response). It seems likely therefore that the frequency 
d e p e n d e n c y  of the r e l a t i v e  c o n t r i b u t i o n  of the 
purinergic and adrenergic elements in sympathetic co­
transmission varies from tissue to tissue, no general 
rule applying.
The administration of rauwolscine highlighted the 
p o t e n t i a l  d i f f i c u l t i e s  e n c o u n t e r e d  w h e n  using an 
antagonist which is not selective for postsynaptic 
alpha2 ~adrenoceptors only. Rauwolscine's action on the 
presynaptic nerve terminal led to increases in the 
height of the responses by interfering with the feedback 
system. This therefore complicates interpretation of 
results since blockade of alpha2-adrenoceptors blocks 
autofeedback and increases release of both transmitters, 
enhancing purinergic and adrenergic contibutions to 
transmission. Therefore in the presence of both prazosin 
and rauwolscine an exaggerated purinergic component may 
be observed. The action of rauwolscine also showed the 
p r o b l e m s  faced w h e n  a n a l y s i n g  results m e r e l y  by 
measuring maximum heights of the responses rather than 
analysing the shape of the response (i.e. its time
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course). Rauwolscine's most obvious action was to 
shorten its duration (Figure 2:7b) indicating perhaps a 
role for post-j u n c t ional a l p h a 2 ” adr e n o c e p t o r  in 
maintaining the pressor response.
mATP attenuates the non-adrenergic component of 
nerve induced contractions of the vas deferens in vitro 
(Burnstock & Sneddon, 1984). We confirmed this in the 
pithed rat to verify the selectivity and the time course 
of blockade of mATP in vivo. Whereas a long-lived 
desensitisation can be maintained in vitro, in the 
pithed rat a parallel rapid loss of mATP's effect was 
clear in both vas deferens and resistance blood vessels, 
making this a critical consideration when employing mATP 
as a blocker of putative purinergic transmission.
Flavahan et al (1985) showed that nerve mediated 
pressor responses could be completely blocked by the 
g a n g l i o n  b l ocker hexamethoniurn. Since the dir e c t  
component of the nerve mediated response is almost 
a b o l i s h e d  by g u a n e t h i d i n e ,  this i n d i c a t e s  that 
electrical stimulation via the pithing rod activates 
preganglionic autonomic nerves and that transmission can 
be stopped at the level of postganglionic adrenergic 
s y m p a t h e t i c  nerve t e r minals, i n d i c a t i n g  that the 
response is mediated by a transmitter / or transmitters 
from the postganglionic sympathetic nerve terminals.
Previously it was shown that the direct pressor
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response to stimulation of the sympathetic outflow could 
be only partially blocked by reserpine suggesting that 
NA is not the only transmitter. However transmission 
could be completely blocked by pretreatment with 6 -OHDA 
suggesting that only nerves possessing uptake and 
accumulation sites for phenylethanolamines are involved 
(Flavahan et al, 1985). This was consistent with the 
h y p o t h e s i s  that the ent i r e  resp o n s e  arises f r o m  
"adrenergic" nerves but part of it (the reserpine- 
resistant element) which does not require NA, is due to 
a co-transmitter. However the earlier failure to abolish 
the response with a combination of mATP and alpha- 
adrenoceptor antagonists left open the possibility of 
another co-transmitter or of an adrenergic response 
which was not mediated by alpha-adrenoceptors (however 
this was unlikely due to reserpine resistance). The 
present results show that this arose because of the 
failure to detect the transience of the blockade by 
mATP.
The calcium channel blocking agent, nifedipine, was 
also able to antagonise the sympathetic nerve mediated 
pressor response. This attenuating effect of nifedipine 
was best observed at higher frequencies of stimulation 
(20 Hz) and could be seen in both alpha-blocked and non­
alpha-blocked preparations. In the presence of prazosin 
and rauwolscine, nifedipine reduced the remaining 
pr e s s o r  response by 50% at 20Hz. N i f e d i p i n e  also 
produced a marked reduction in the nerve mediated
106
p r e s s o r  r e s p o n s e  in the ab s e n c e  of the alpha-  
adrenoceptor antagonists. However nifedipine had very 
little effect on the vasopressor response that remained 
after desensitisation with mATP. This perhaps indicates 
nifedipine and mATP are acting on the same component and 
since prazosin did not affect the blocking effects of 
n i f e d ipine,  then it is likely that p r a z o s i n  and 
nifedipine are acting on different components of the 
vasopressor response.
At higher frequencies more of the non-adrenergic
component of the pressor response in vascular smooth
m u s c l e  is observed. These e l e c t r i c a l l y  d e p e n d e n t
2 +r e s p o n s e s  are m e d i a t e d  via e.j.p.s and slow Ca 
c h a n n e l s  and t h e r e f o r e  w e r e  m o r e  s u s c e p t i b l e  to 
nifedipine. The adrenergic component of the response was 
largely unaffected by nifedipine as would be expected if 
the activation of alpha-adrenoceptors led to decreases 
in c a l c i u m  b i n d i n g  t h e r e f o r e  i n c r e a s i n g  t h e  
concentration of free calcium to produce contractile 
responses. Nifedipine's effects on alpha-adrenoceptor 
mediated responses might therefore only be 'seen during 
prolonged agonist infusions, where prolonged contractile 
responses require more extracellular calcium (McGrath & 
O'Brien, 1987).
This action of nifedipine is analogous to its 
action in the vas deferens. The mechanical response of 
the vas deferens to single pulses or short trains of
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stimuli comprises two distinct phases: (Ambache & Zar,
1971; McGrath, 1978) an initial twitch, which may be 
attributed to purinergic involvement; and a slow well 
maintained secondary contraction attributed to NA 
release. N i f e d i p i n e  a b o l i s h e s  the initial t w i t c h  
component but leaves the secondary component intact 
(French & Scott, 1981). In the vas deferens nifedipine 
acts to abolish the smooth muscle action potential and 
the initial twitch response, without reducing the 
excitatory junction potentials (e.j.p.s) which were 
measured by intracellular electrodes (Blakely et al, 
1981). This suggests that there was a difference in the 
receptor-response coupling of the two components of the 
response.
The sites of action for nifedipine in preventing 
the initiation of the smooth muscle action potential and 
hence in blocking the initial twitch, can be seen from 
the digrammatic representation of the theory behind 
sympathetic neuro-effector coupling in smooth muscle in 
Figure 2:23. Ca^+ is the ion carrying most of the inward 
current during the rising phase of the action potential 
(Bennet, 1967). The initial twitch corresponds to the 
contraction associated with the smooth muscle action 
potential. Since in the vas deferens, the e.j.p.s which 
summate to initiate the smooth muscle action potential 
and associated contraction, are resistant to alpha- 
adrenoceptor antagonists, it seems that the alpha- 
adrenoceptor mediated contractile response of the v a s
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deferens does not require an action potential and thus 
does not work through the potential operated channel 
pathway (Figure 2:23).
By analogy this explains the results obtained in 
the pithed rat preparation with nifedipine, especially 
since similar electrophysiological results to those in 
the vas deferens, have now been found in arteriolar 
smooth muscle (Hirst & Neild, 1980) where e.j.p.s are 
resistant to alphaj-adrenoceptor blockade. In the 
i s o l a t e d  a r t e r i o l a r  s m o o t h  muscle, i o n t o p h o r e t i c  
application of NA gave contractile responses which 
occurred without any detectable change in membrane 
potential, again comparing well with the adrenergic 
mediated response to nerve stimulation in the vas 
deferens which occurred independently of the action 
potential.
Hirst & Neild (1980) explained these results in 
vascular smooth muscle by postulating the existence of a 
gamma-adrenoceptor which could not be antagonised by 
alpha-adrenoceptor antagonists but which could be 
activated by neuronally released NA and could mediate 
contraction via e.j.p.s and hence action potential 
propagation. However they had no direct evidence that 
the nerve induced e.j.p. was caused by NA.
A more likely explanation of the results is that 
ATP and NA are released together as co-transmitters from
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the sympathetic nerve terminal (Figure 2:23). This 
explains the observations made in the vas deferens and 
isolated vascular smooth muscle as well as explaining 
the results of the present study of sympathetic mediated 
vasopressor responses of rat resistance vessels in vivo. 
Neuronally released NA activates alpha^- and alpha 2 ~ 
adrenoceptors on the effector smooth muscle to operate 
the 'receptor operated channels' (R.O.C.s) and possibly 
also cause a decrease in Ca2+ binding, which results in 
an increase in free intracellular Ca2+ . In contrast 
noradrenaline's co-transmitter ATP acts through P2  
receptors to elicit e.j.p.s which initiates propagated
o +
action potentials, which open V.O.C.s, allowing Ca 
entry and hence leading to contraction of smooth muscle.
E v i d e n c e  fro m  Sneddon & B u r n s t o c k  (1984) is 
compatible with this theory since they showed that the 
P 2 “ purinoceptor desensitising agent mATP, blocked the 
e.j.p.s in the guinea pig vas deferens.
All of the data is now c o n s i s t e n t  w i t h  the 
hypothesis that NA and ATP can act as co-transmitters at 
vascular neuroeffector junctions and produce additive 
responses through only alpha-adrenoceptors and P2- 
purinoceptors, respectively.
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SECTION III
HISCII.S£IQH
In attempting to localise the vascular bed or beds 
involved in the depressor responses to stimulation of 
the spinal outflow between regions L 5  and S2 * the 
vascular beds of the lower gut (colon) and the hind limb 
being the most obvious with respect to location and 
relative contribution to systemic blood pressure, were 
studied, but clear conclusions could still not be drawn.
The involvement of the gut in these responses 
seemed the more likely since the vasodepressor response 
occurs in similar circumstances to the inhibitory nerve- 
mediated response of the anococcygeus muscle (McGrath, 
1973). H o w e v e r  since o c c l u s i o n  of the m e s e n t e r i c  
vasculature led to a drop in the resting blood pressure 
level (presumably by decreasing the venous return and 
c a r d i a c  o u t p u t )  t h e n  t h i s  w o u l d  c o m p l i c a t e  
interpretation of data obtained. Such a drop in blood 
p r e s s u r e  itself is m i g h t  have c o n t r i b u t e d  to the 
disappearance of nerve induced depressor responses, if 
accompanied by a decrease in vascular smooth muscle 
tone, without considering the effect of removing the 
mesenteric circulation from the system. However since 
the subsequent increase in blood pressure, caused by 
adding guanethidine (lOmg/kg) to these preparations, 
still did not bring back the depressor responses, then 
it may be reasonable to assume that the mesenteric 
v a s c u l a t u r e  is i n v o l v e d  in t h e  n e r v e  i n d u c e d
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vasodepressor response.
Dusting & Rand (1972) found that when the blood 
pressure of the pithed rat was raised by NA infusion, 
the response to spinal stimulation had a more distinct 
depressor component. Subsequent studies (McGrath, 1973; 
Gardner, 1977) employed either guanethidine or the 
indirectly acting sympathomimetic tyramine, to increase 
resting blood pressure levels before study of the 
vasodepressor responses commenced.
In the present study it was possible to obtain 
depressor responses without the addition of such agents. 
However the intravenous administration of guanethidine 
(lOmg/kg) led to increases in the magnitude of the 
depressor responses obtained on stimulation of the 
spinal outflow. These increases were not due only to the 
i n c r e a s e d  r e s ting b l o o d  p r e s s u r e  level c a u s e d  by 
guanethidine, since this effect was also observed in 
preparations pretreated with atropine, propranolol, 
prazosin and rauwolscine. In these preparations with 
adrenergic and cholinergic blockade, guanethidine did 
not produce the large pressor responses observed in the 
untreated animals. Therefore guanethidine's effect was 
not simply due to an increased blood pressure level. One 
possible explanation could be that the additions of 
adrenergic antagonists did not all reach the site of 
action or were successfully competed against by the 
neurotransmitters, so that complete blocked of alpha-
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and beta-adrenoceptors was not attained. This seems 
unlikely due to the high dosage of antagonists employed. 
Alternatively guanethidine may also be blocking the 
e x c i t a t o r y  a c tions of a c o - t r a n s m i t t e r  r e l e a s e d  
alongside NA from the adrenergic nerve terminals. This 
would therefore unmask the full depressor effect of the 
inhibitory transmitter.
Since guanethidine did not block the depressor 
responses, it is likely that the inhibitory transmitter 
is not a co-transmitter in adrenergic nerve terminals 
but rather is released at another nerve type, either as 
the main neurotransmitter (eg. 'pure' purinergic nerves) 
or as a co-transmitter (eg. released alongside Ach).
Although 8 PT (lOmg/kg) and mATP had no effect on 
the vasodepressor response, it is still not possible to 
completely rule out purinergic involvement in these 
responses. Since mATP is a V2x desensitising agent, thus 
b l o c k i n g  the e x c i t a t o r y  acti o n  of ATP, then any 
i n h i b i t o r y  r e s p o n s e s  of ATP a c t i n g  t h r o u g h  p2y~ 
purinoceptors will remain unaffected. Burnstock & 
Warland (1987) showed that ATP relaxes rabbit mesenteric 
artery via the P 2 y-pur i n o c e p t o r  and that this 
inhibitory action of ATP could be blocked by Reactive 
Blue 2.
In the m a j o r i t y  of p r e p a r a t i o n s ,  g a l l a m i n e  
(lOmg/kg) had no effect on the depressor responses. This
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is in agreement with a previous study by McGrath (1973). 
In the few preparations where the depressor responses 
were abolished it could be that gallamine was acting 
non-specifically in causing ganglionic blockade (Blaber 
et al, 1985). Dusting & Rand (1972) suggested that the 
depressor response is a result of skeletal muscle 
causing an 'arterial clamping effect', thus increasing 
peripheral resistance and causing an increase in blood 
pressure, therefore leading to the secondary depressor 
r esponse f o l l o w i n g  s t i m u l a t i o n  a t t r i b u t e d  to a 
functional hyperaemia in the stimulated muscles, however 
this s e e m s  unlikely. Other e v i d e n c e  a g a i n s t  the 
d e p r e s s o r  r esponse being a result of f u n c t i o n a l  
hyperaemia is that the vasodepression occurs between 1  
and 2  seconds after the start of stimulation, which 
would be too rapid onset for this type of mechanism to 
occur. Neither is it likely that overflow of ACh from 
ganglionic synapses and skeletal neuromuscular junctions 
could exert a vasodilator action since atropine had no 
effect on these responses.
McGrath (1973) showed that these responses were 
susceptible to blockade by the ganglion blocking agent 
hexamethonium, suggesting that the depressor fibres are 
organised in the pattern of the autonomic nervous system 
with a ganglion relay. It is also possible that the 
vasodepression could be due to the effect of endothelium 
derived relaxant factor (EDRF) which would be released 
from the endothelium of the blood vessels by a non-
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a d r e n e r g i c  n e u r o t r a n s m i t t e r  ( s i n c e  a d r e n e r g i c  
transmission would be blocked by guanethidine). This 
effect of EDRF may be present throughout the spinal 
outflow but is apparent only in this region where there 
are no large pressor effects to hide any dilator action. 
Stimulation of the sacral outflow in the presence of an 
agent which will block the action of EDRF in vivo might 
throw more light on this possibility.
Peptidergic involvement may also be a possibility. 
Substance P is not only a potent releasing agent of EDRF 
but it can also mediate, via a local axon mechanism in 
the gut, vasodepressor responses in the intact animal 
(Lembeck & Skofitisch, 1982). However the peptidergic 
involvement in vasodepressor responses has yet to be 
fully elucidated and awaits further development of 
specific antagonists of Substance P.
Dorsal root vasodilator fibres cause a vasodilation 
in skeletal muscle and superficial mucus membrane 
(Holton, 1959). Their physiological role is to produce 
arteriolar dilation as a response to local injury. The 
sensory C fibres supplying the skeletal muscle branch 
peripherally and sensory stimulation of these fibres 
causes impulses to pass both centrally and by the 
peripheral branch to arterioles in the vicinity. These 
dilate and their response causes the 'flare' of the 
'triple response' (Lewis, 1927). Although the peripheral 
transmitter is unknown, Substance P involvement in at
115
least the afferent pathway is likely. In a study of the 
sacral parasympathetic outflow to the colon (S£ - S3 ) 
Hulten and co-workers (1969) found that stimulation 
produced colonic contraction, a large vasodilation in 
the vascular bed of the colon and an associated intense 
f l u s h in g of the c o l onic mucosa. The v a s o d i l a t i o n  
response was unaffected by atropine and was abolished by 
ganglionic blockade, indicating an autonomic non- 
cholinergic mechanism of transmission.
Other substances studied in relation to the nerve 
induced vasodepressor responses include bradykinin and 
histamine (Gardner, 1977) as well as prostaglandins 
(Murray, 1978), none of which seem to play a role in the 
nerve mediated depressor responses.
Therefore it seems that these depressor responses 
obtained by stimulation of the spinal outflow at regions 
L 5 -S 2 1 are NANC, are mediated through a ganglionic 
pathway but the peripheral transmitter has yet to be 
identified.
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SECTION IXL DISCUSSION
117
PROFILES .QF AGONISTS Q R  THE AIRWAYS
The first agent tested in these preparations was 
ACh. This served as a test for the viability of the 
preparation before proceeding with the experimental
produced dose dependent bronchoconstrictions which were 
antagonised by the muscarinic antagonist atropine as 
w e r e  the b r o n c h o c o n s t r i c t o r  r e s p o ns es  to ne r v e  
stimulation in low resting airway smooth muscle tone.
The i n t r a v e n ou s a d m i n i s t r a t i o n  of a d e n o s i n e  
resulted in marked bronchoconstriction which lasted over 
5 minutes. This bronchoconstriction was potentiated by 
dipyridamole (lOmg/kg) and was blocked by either 8 PT 
(lOmg/kg) or aminophylline (lOmg/kg). No bronchodilator 
responses were observed to intravenously administered 
adenosine even in preparations undergoing 5HT infusions. 
A d m i n i s t r a t i o n  of the a d e n o s i n e  a n a l o g u e ,  2- 
chloroadenosine and the P 2 X-purinoceptor desensitising 
agent also produced bronchoconstrictions.
The major effect of adenosine and its nucleotides 
on airway musculature, has in the past been reported to 
be relaxatory (Bennet & Drury, 1931; Coleman, 1976) both 
in vivo and in vitro. However in this study, the effect 
of adenosine (and mATP) was excitatory. A recent report 
by Pauwels and Van der Straeten (1986) shows that the in
protocol. ACh (10 administered intravenously
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vivo intravenous administration of adenosine caused 
bronchoconstriction in the rat. This bronchoconstricting 
effect was also observed in human airways (Holgate et 
alf 1986) when adenosine was administered as an aerosol 
to patients with asthma.
Since the P^-purinoceptor antagonist 8PT (lOmg/kg) 
attenuated the nerve-mediated bronchodilations and 
increased the nerve-mediated bronchoconstrictions it may 
be said that the neuronal responses attributable to 
adenosine are inhibitory and are probably mediated via 
purinoceptors, therefore there is the possibility 
that the excitatory responses produced by intravenous 
administrations of adenosine may not be mediated via the 
same population of receptors and could be mediated via 
a non-receptor mechanism. For example Welton & Simko 
(1980) suggested that adenosine-mediated effects in lung 
tissue in sensitised animals were a result of antigen- 
induced histamine release, unlike those to ATP, which 
causes histamine release from mast cells. This would 
explain observations made in patients with asthma but 
does not explain the results of the present study with 
non-sensitised animals. Therefore adenosine may be 
i n t e r a c t i n g  w i t h  the lung e p i t h e l i u m  to release  
bronchoconstricting agents, like prostaglandins, as 
suggested by Kamikawa & Shimo (1976). This could explain 
t h e  b r o n c h o c o n s t r i c t o r  a c t i o n  o b s e r v e d  w h e n  
administering adenosine intravenously. Pauwels & van Der 
Straeten (1986) also suggested that adenosine action in
119
the lung is i n d i r e ct  and that a d e n o s i n e  i n d u c e d  
bronchoconstriction is antagonised by high doses of 
atropine.
Therefore in the lung adenosine could well have 
more than one effect , for example: relaxation of airway 
s m o o t h  m u s c l e  (probably via p o s t s y n a p t i c  ? i a- 
purinoceptor); contraction (by releasing prostaglandins 
from the lung epithelium, or alternatively by activating 
a ^-purinoceptor to produce contraction); and a 
p r e s y n a p t i c  effect on the p a r a s y m p a t h e t i c  n e r v e  
t e r m i n a l .  T h i s  is all c o n s i s t e n t  w i t h  the 
pharmacological from this present study.
These effects may occur together but the dominating 
effect would depend on the tone of the smooth muscle and 
on the localisation adenosine and its accessibility to 
Pj-purinoceptors, and thus would depend on whether the 
r'ather labile adenosine was given i.v. or was released 
duri n g  n e rve stimulation. The f o l l o w i n g  e x a m p l e s  
illustrate how this can occur and explain our main 
experimental observations.
1) In high tone, stimulation of the vagal nerve bundle 
may release adenosine (probably as a co-transmitter) 
which acts on Pla-purinoceptors to cause relaxation. Any 
excitatory effects of neurally released adenosine would 
be masked in this instance.
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2) In low tone, nerve released adenosine acting on Pia” 
purinoceptors might produce no detectable effect since 
the smooth muscle tone is too low to see any relaxation, 
but intravenously administered adenosine could cause 
release of histamine or 5HT from mast cells and hence 
produce contractions.
3) C o n s i d e r  l o w  t o n e  w h e r e  the n e r v e  i n d u c e d  
bronchoconstriction is increased after the addition of 
8PT. The latter could be acting to block the negative 
feedback effect of adenosine (via P^-purinoceptors) on 
ACh release on the parasympathetic nerve terminal. 
Therefore more ACh will be released. Alternatively this 
could be explained by postsynaptic mechanisms again 
assuming that ACh and adenosine are co-transmitters, but 
this time the released ACh acts on muscarinic receptors 
in the airway smooth muscle to constrict it whilst the 
a d e n o s i n e  r e l e a s e d  along w i t h  it acts on P^- 
purinoceptors to produce relaxation of smooth muscle. 
T h e r e f o r e  by b l o c k i n g  these p o s t - s y n a p t i c  P^- 
purinoceptors an increase in the excitatory response 
occurs.
Previous studies have shown that both ATP and 
adenosine have a direct action on smooth muscle and that 
this can be excitatory (Collier et al, 1966), inhibitory 
(Coleman, 1976) or biphasic (Kamikawa & Shimo, 1976). 
The responses often are dependent on intrinsic smooth 
muscle tone.
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Early studies showed that adenosine and adenine 
nucleotides caused bronchial dilatation in guinea pigs 
in vivo (Bennet & Drury, 1931). In vitro studies have 
also shown this (Bianchi et al, 1963). For example 
adenosine and adenine nucleotides caused bronchial 
dilatation in perfused guinea pig lungs and in isolated 
guinea pig trachea (Coleman, 1976).
Farmer & Farrah (1976) found that adenosine and 
adenine nucleotides all produced a contraction followed 
by a relaxation in the high spontaneous tone guinea pig 
tracheal tube preparation. They explained this biphasic 
response on the basis that the direct effect of these 
compounds was excitatory but they were then broken down 
to i n o s i n e  and A M P  w h i c h  w o u l d  then m e d i a t e  the 
relaxation. Kamikawa & Shimo (1976) showed that the 
biphasic action of ATP on guinea pig tracheal strips was 
antagonised by a prostaglandin antagonist and mimicked 
by PGE 2 f therefore they concluded that the response to 
ATP was indirect and mediated by PGE 2  released via 
stimulation of its biosynthesis.
An unexpected observation was made when adding the 
p^-purinoceptor antagonist 8 PT, in that it produced a 
bronchoconstriction. The bronchoconstriction to 8 PT 
could have a number of causes.
Firstly, 8 PT could be a purinergic partial agonist.
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H o w e v e r  this s e e m s  to be the l east likely of the 
possibilities since aminophylline in a dosage which 
blocked the adenosine response did not block this 8 PT 
response.
Secondly, 8 PT could be acting in an antagonistic 
capacity. Parasympathetic co-transmission of excitatory 
ACh and inhibitory adenosine together could keep the 
resting tone of the airway smooth muscle lower than if 
ACh was the sole transmitter. Assume that the lung is 
under the constant neural inhibitory influence of 
adenosine. 8 PT in antagonising the inhibitory action of 
adenosine would thus increase the tone of the lung. 
Consequently it would appear as if 8 PT itself was 
causing a contraction by acting as an agonist whereas it 
would be removing an inhibition. Similar observations 
were made by Baer and coworkers in 1983. They suggested 
that increased contractile activity in the DNECA (an 
adenosine analogue) relaxed isolated longitudinal muscle 
of rabbit small intestine on addition of 8 PTf was due 
to 8  PT a n t a g o n i s i n g  D N E C A  and so r e v e r s i n g  the 
relaxation.
Alternatively, the effect may be independent of 
purinoceptors. 8 PT may increase calcium sensitivity and 
or internal calcium moblization and so cause contraction 
of the m u s c l e  m u c h  in the s a m e  w a y  as does the 
structurally similar caffeine (Weber & Herz, 1968).
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An 8 PT vehicle effect (PEG/NaOH) was also ruled out 
as being responsible for bronchoconstriction. The 
vehicle on its own had no effect on the respiratory 
system. As the drug is so difficult to dissolve another 
possibility is that after intravenous administration, 
the 8 PT crystallises out and so may produce an effect by 
a physical mechanism. This could also explain the large 
decrease in blood pressure that often (but not always) 
accompanied these bronchoconstrictor responses.
In some preparations, in conditions of high resting 
tone, a d d i t i o n a l  inc r e a s e s  in tone c a u s e d  by 8  PT 
a d m i n i s t r a t i o n  led to the onset of s p o n t a n e o u s  
breathing. This may have been a result of abnormal blood 
gas levels (caused by a prolonged increase in tone), or 
by stimulation of J-receptors or irritant receptors 
(Barnes, 1986). Stimulation of these irritant receptors 
might be responsible for the bronchoconstricting effect 
of 8 PT in low tone.
The P2 ~purinoceptor desensitising agent mATP, may 
be causing bronchoconstriction by the same mechanisms as 
reported for ATP ( Diamant & Kruger, 1967; Sugiyama & 
Yamasaki, 1969; Sugiyama, 1971). In these reports ATP 
was identified as a histamine liberator via action on 
mast cells. However an additional mechanism has been 
reported for ATP: that is, the ability of ATP to release 
prostaglandins from the lung endothelium (Kamikawa & 
Shimo,1976). This report suggests that the ATP-induced
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r e s p o n s e  in the lung w a s  in d u c e d  and m e d i a t e d  by 
prostaglandins since the response could be antagonised 
by indomethacin and mimicked by PGE 2 * However this 
mechanism is associated with bronchodilation rather than 
bronchoconstriction.
It was not possible to construct dose/response 
curves for mATP since the bronchoconstrictor responses 
to mATP were subject to tachyphylaxis. Another problem 
encountered in this part of the study was the ability of 
mATP to cause the secretion of large amounts of mucus 
from the lung. A recent report by Rice & Singleton 
(1986) proposed P 2 ~purinoceptor involvement in the 
regulation of surfactant secretion from rat isolated 
alveolar cells. It is possible that P2 ~purinoceptors are 
involved in the production of mucus also.
Evidence indicates that compounds such as adenosine 
and ATP may act as modulators in some tissues (Fredholm 
& Hedqvist, 1980; Ribeiro, 1979; Stoner 1981). These 
modulating roles include those on neurotransmission, 
receptor sensitivity, smooth muscle reactivity and local 
blood flow, all of which are of importance in this 
present study. It has been suggested that bronchial 
asthma may be a result of an abnormality of these 
purinergic modulations.
Bronchial asthma is induced mainly by antigen- 
antibody reaction and, when allergens bind to specific
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i m m u n o g l o b u l i n  (IgE), c h e m i c a l  m e d i a t o r s  such as 
histamine are released from mast cells and basophils. 
These mediators cause the clinical symptoms observed 
during an asthmatic attack as well as contributing to 
hyperreactivity of airway smooth muscle. Another factor 
contributing to this hyperreactivity of airway smooth 
muscle could be the hyperfunction of parasympathetic 
ner v e s  (Wi d d i c o m b e ,  1979). This h y p e r f u n c t i o n  of 
parasympathetic nerves could be comparable to the 
increased bronchoconstriction induced by stimulation of 
the vagus after the addition of 8 PT.
Apart from this possible purinergic involvement in 
the hyperfunction of parasympathetic nerves there are 
other links between purines and asthma. For example, ATP 
itself is released during the antigen-antibody reaction 
and it can cause many of the symptoms of an asthmatic 
attack. Aerosol administered ATP has been reported to 
cause bronchoconstriction in asthmatic humans (Holgate 
et al, 1986). ATP can liberate histamine from mast cells 
directly through a calcium dependent process, hence 
releasing histamine which contributes to asthmatic 
symptoms (Sugiyama, 1971). Adenosine, unlike ATP does 
not release histamine itself but it does induce the 
antigen-induced histamine release from tissue (Welton & 
Simko, 1980) and mast cells (Fredholm & Sydbom, 1980). 
Adenosine also is released during the antigen challenge.
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NERVE MEDIATED RESPONSES.
Exploration of parameters suitable for vagal bundle 
stimulation showed that a frequency of 15Hz at 25v for 
3 0 s e c  ( 0 . 5 m s  p u l s e  w i d t h )  g a v e  a g o o d  
bronchoconstriction when the airway smooth muscle had 
low resting tone as well as giving good bronchodilation 
in conditions of high resting tone of the airway smooth 
m u s c l e .  P r e v i o u s  i n v e s t i g a t i o n s  of the N A N C  
bronchodilation response have used similar stimulatory 
p a r a m e t e r s .  D i a m o n d  & O'Donnell (1980) o b t a i n e d  
bronchodilations at frequencies between 1 and 100 Hz at 
30v for 5 sec (pulse width 1ms), whereas Irvin et al 
(1980) stimulated at a frequency of 30Hz (0.5ms pulse 
width) throughout but varied the voltage (10-40v). When 
studying the effects of the adenosine uptake inhibitor, 
dipyridamole, on the nerve induced bronchodilations, it 
became apparent that stimulation at frequencies of 15Hz 
were not suitable for this particular part of the study. 
The bronchodilations produced under these conditions 
were usually maximal, reaching a level comparable to the 
resting tone of the airway smooth muscle before the 
start of the 5 HT infusion. Therefore in order to leave 
the possibility of an increase in the bronchodilation by 
any agent (such as d i p y r i d a m o l e ) ,  a s u b - m a x i m a l  
frequency of 5Hz was employed.
Rather than just stimulating the parasympathetic
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branch (the vagus), the isolated and sectioned cervical 
vagosympathetic nerve bundle was stimulated and alpha 
and beta adrenoceptor antagonists were added to block 
out the a d r e n e r g i c  effects. This o v e r c a m e  any 
difficulties which could have arisen due to damage of 
the parasympathetic branch, which is thought to be 
responsible for both the NANC transmitter as well as the 
excitatory transmitter ACh, or even VIP (Polak & Bloom, 
1986) or the consequences of including stray sympathetic 
f i b r e s  w h i c h  w o u l d  h a v e  m a d e  e x p e r i m e n t a l  
interpretations difficult.
The bronchoconstriction produced by stimulation of 
the vagal bundle in low resting airway smooth muscle 
tone was certainly cholinergic, and thus likely to be 
m e d i a t e d  by the p a r a s y m p a t h e t i c  branch, since 
propranolol, prazosin and idazoxan did not affect the 
r e s p o n s e s  and a t r o p i n e  at a dose level of l m g / k g  
completely blocked them. Also the bronchoconstrictor 
responses produced by vagal stimulation compared well 
with those obtained by intravenous administration of 
ACh.
The effect of the P^-purinoceptor antagonist 8 PT, 
on the nerve induced bronchoconstriction, was to enhance 
the level of bronchoconstriction produced. One possible 
explanation of this could be that 8 PT is acting by 
inhibiting an adenosine negative feedback system which 
w o u l d  n o r m a l l y  i n h i b i t  the r e l e a s e  of the
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neurotransmitter (ACh) or co-transmitters (ACh with ATP 
or adenosine), thus more of the excitatory transmitter 
is released. Alternatively 8 PT may be acting to reduce 
the effective adenosine component of transmission 
(either pre-junctionally by blocking the release of 
adenosine, or p o s t - j u n c t i o n a l l y  by b l o c k i n g  the 
inhibitory action of adenosine on the smooth muscle via 
Pj-purinoceptors). The bronchoconstriction produced by 
the intravenous administration of ACh was not affected 
by 8 PT, therefore it is unlikely that 8 PT was acting to 
potentiate the action of released ACh post-junctionally. 
Gustaffson and co-workers (1986) reported an adenosine/ 
cholinergic interaction in transmission in the rabbit 
b r o n c h i  but they c o n c l u d e d  that this i n t e r a c t i o n  
resulted in an adenosine enhancement of cholinergic 
transmission and not inhibition.
NERVE MEDIATED RESPONSES IN HIGH RESTING AIRWAY SMOOTH 
MUSCLE TONE
The bronchodilatory responses reached their maximum
5 - 3 0  seconds after nerve stimulation had stopped. This 
may indicate that some p r o c e s s  m u s t  occur b e f o r e  
activation of the receptor on the smooth muscle cell 
which leads to the response. For example there may be 
either breakdown of the released transmitter to the 
actual receptor ligand (e.g. ATP to adenosine, if ATP 
rather than adenosine was the released co-transmitter) 
or the r e l e a s e  of a n o t h e r  s u b s t a n c e  (e.g. a
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prostaglandin from the lung epithelium (Kamikawa & 
S h i m o ,  1976) ), w h i c h  w o u l d  t h e n  m e d i a t e  the
b r o n c h o d i l a t i o n  r a t h e r  t h a n  a d e n o s i n e  i t s e l f .  
Alternatively the receptor inhibition-coupling may be a 
slow process. This is not unusual for an inhibitory 
process since it requires the removal of the active tone 
and may for example involve the spontaneous loss of some 
substance or the active pumping or binding of another 
(e.g. Ca2+ ions).
These responses were not reduced by sequential 
intravenous injections of atropine,propranolol, prazosin 
and idazoxan. This confirmed other peoples findings that 
these response were non-adrenergic non-cholinergic 
(Diamond & O'Donnell, 1980; Irvin et al, 1980).
D i a m o n d  & O'Donnell (1980) r e p o r t e d  that the 
bronchodilation produced by vagal stimulation appeared 
to increase after atropine had been added. This was 
probably caused by taking elimination of the contractile 
part of the biphasic response which they observed in 
this p r e p aration, t h e r e f o r e  the full effect of 
bronchodilation was unmasked.
Propranolol made no significant difference to the 
o b s e r v e d  b r o n c h o d i l a t i o n ,  i n d i c a t i n g  that this 
bronchodilation is unlikely to be due to release of NA 
from the sympathetic branch. Stimulation of beta- 
adrenoceptors by release of NA from sympathetic nerves
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has been reported to cause bronchodilation in the cat in 
vivo (Diamond & O'Donnell, 1980; Diamond & Gillespie, 
1982). However the NANC bronchodilation is the larger 
(both in magnitude and in time course ) and dominates 
over the smaller sympathetic modulated bronchodilation 
(Irvin et al, 1980).
A c o m b i n a t i o n  of p r a z o s i n  and i d a z o x a n  (or 
rauwolscine) used for alpha^- and alpha 2 ~a<3 renoceptor 
blockade, had no e f f e c t  on the b r o n c h o d i l a t i o n  
responses, therefore eliminating the likelihood of the 
involvement of alpha-adrenoceptors in this response.
The Pi antagonist 8 PT caused a small reduction in 
the neurally evoked bronchodilatory response in the 
presence of muscarinic and alpha and beta-adrenoceptor 
blockade. However following the administration of the 
adenosine uptake inhibitor dipyridamole (lOmg/kg), it 
w a s  found that a t t e n u a t i o n  of the b r o n c h o d i l a t o r  
response caused by 8 PT was more marked a frequency of 
s t i m u l a t i o n  of 15Hz. The a t t e n u a t i n g  effe c t  of 
dipyridamole / 8 PT pretreatment is best shown at a 
submaximal frequency of 5Hz.
8 PT (lOmg/kg) could have reduced the nerve induced 
bronchodilation by antagonising an inhibitory effect of 
adenosine (which is released by nerve stimulation) on 
the airway smooth muscle. For example if adenosine is 
acting postjunctionally as an inhibitory transmitter
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relaxing the precontracted airway smooth muscle 8 PT will 
a n t a g o n i s e  this. A l t e r n a t i v e l y ,  8 PT m a y  act 
p r e s y n a p t i c a  1 1 y r e d u c i n g  t h e  o u t p u t  of a 
bronchoconstricting transmitter such as Substance P 
(Barnes, 1986) rather than ACh.
The addition of the adenosine uptake inhibitor 
dipyridamole (lOmg/kg) enhanced the blocking effect of 
8 PT on the nerve induced bronchodilatory response. 
D i p y r i d a m o l e  on its o w n  d i d  n o t  a f f e c t  the  
bronchodilatory responses at 15Hz stimulation, but 
responses were probably maximal so that increases in 
bronchodilation could not be expected. At submaximal 
b r o n c h o d i l a t i o n  p r o d u c e d  by 5Hz s t i m u l a t i o n ,  the 
p o t e n t i a t i n g  e f f e c t s  of d i p y r i d a m o l e  on the  
bronchodilation could be observed. In explaining this, 
perhaps 8 PT is a substrate for the cellular uptake 
process for adenosine and dipyridamole, by blocking 
this, makes more 8 PT available at the post-synaptic P^- 
p u r i n o c e p t o r  sites on the a i r w a y  s m o o t h  muscle. 
Alternatively, dipyridamole might potentiate pre and 
postsynaptic effects of adenosine resulting in reduced 
t r a n s m i t t e r  output t h e r e f o r e  1 ) less resp o n s e  is 
mediated by other transmitters, and 2 ) more of the 
response is ATP/adenosine mediated, so overall, 8 PT will 
block more effectively, since the response is maintained 
by a lower concentration of ATP/adenosine acting at more 
sites (due to loss of uptake) therefore the antagonist 
8 PT can compete more effectively.
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Another P^-purinoceptor antagonist, aminophylline 
(lOmg/kg), also slightly reduced the bronchodilatory 
response, again indicating a Pj component to the NANC 
response. The administration of aminophylline produced a 
s h o r t  l a s t i n g  d e c r e a s e  in 5 H T - i n d u c e d  tone. 
Aminophylline is used in asthma therapy for relaxation 
of bronchial smooth muscle. The mechanism of action of 
aminophylline and other theophylline type drugs is 
r e g a r d e d  as m a i n l y  t h r o u g h  c y c l i c  n u c l e o t i d e  
phosphodiesterase inhibition and only partly through 
adenosine antagonist action (Fredholm et al, 1979). This 
would explain why a relaxation was not observed with 
8 PT, since 8 PT is thought to be virtually without 
phosphodiesterase action (Smellie et al, 197 9).
The P2-purinoceptor desensitising agent mATP did 
not s i g n i f i c a n t l y  a n t a g o n i s e  the v a g a l l y  i n d u c e d  
bronchodilation either in the presence or in the absence 
of atropine, 8 PT and the alpha and beta-adrenoceptor 
antagonists. Since the P2x-desensitising agent, mATP, 
was ineffective, the response under study is another 
example of an inhibitory NANC response which does not 
involve P2 x” P u r inoceptors. This m i g h t  t h e r e f o r e  
indicate that these responses have P^ rather than P2” 
purinoceptor mediated components. However since mATP is 
specific for the excitatory P2 x-purinoceptors, it will 
have no effect on P 2 y“ Purinoceptors through which ATP 
acts to produce relaxatory/inhibitory effects. It
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therefore is not possible to rule out P 2 ~purinoceptor 
involvement in these responses until a suitable p 2 y” 
purinoceptor antagonist can be found and tested against 
these responses.
In conclusion, it is not yet possible to state the 
exact physiological and pathophysiological importance of 
purines in the lung, but since the purinergic agonists 
adenosine and mATP show that purinergic receptors are 
present and functional, from the findings of the present 
study, it can be said that purines do play a role in 
lung function, since the NANC inhibitory nervous system 
in the airways of the cat is at least partly purinergic 
mediated.
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